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Eukaryotic genes are mostly composed of a series of exons intercalated by sequences with no 
coding potential called introns. These sequences are generally removed from primary 
transcripts to form mature RNA molecules in a post-transcriptional process called splicing. An 
efficient splicing of primary transcripts is an essential step in gene expression and its 
misregulation is related to numerous human diseases. Thus, to better understand the dynamics 
of this process and the perturbations that might be caused by aberrant transcript processing, it 
is important to quantify splicing efficiency. In this thesis, I introduce SPLICE-q, a fast and 
user-friendly Python tool for genome-wide SPLICing Efficiency quantification. It supports 
studies focusing on the implications of splicing efficiency in transcript processing dynamics. 
SPLICE-q uses aligned reads from RNA-Seq to quantify splicing efficiency for each intron 
individually and allows the user to select different levels of restrictiveness concerning the 
introns’ overlap with other genomic elements, such as exons from other genes. I demonstrate 
SPLICE-q’s application using three use cases including two different species and 
methodologies. These analyses illustrate that SPLICE-q can detect a progressive increase of 
splicing efficiency throughout a time course of nascent RNA-Seq and it might be useful when 
it comes to understanding cancer progression beyond mere gene expression levels. 
Furthermore, I provide an in-depth study of time course nascent BrU-Seq data to address 
questions concerning differences in the speed of splicing and the underlying biological features 







This thesis is an original work by Verônica Rodrigues de Melo Costa and it will provide a 
detailed study on RNA splicing kinetics and dynamics developed over the course of five years. 
The work is divided into Introduction, Materials and Methods, Results, Discussion and 
Conclusion. In detail, Chapter I contains a detailed introduction of the basic concepts of 
molecular biology focusing mainly on pre-mRNA splicing, its regulatory mechanisms, and 
how its misregulation impacts the functionality of the cell. It also introduces RNA sequencing 
and its key applications, and what and how bioinformatics approaches can be applied to better 
understand splicing; Chapter II describes the materials and methods for the study, including 
details on the tools and algorithms used;  Chapter III introduces the approach used to develop 
SPLICE-q, an up-to-date and user-friendly tool for splicing efficiency quantification; Chapter 
IV shows the usefulness of SPLICE-q by applying it to various datasets; Chapter V consists 
of an in-depth study addressing questions concerning the differences in the speed of splicing 
and the underlying biological features that might be associated with it; and Chapter VI 
provides a detailed discussion of the most prominent results and a conclusion. Portions of 
Chapters III and IV have been published as: V. R. Melo Costa, J. Pfeuffer, A. Louloupi, U. A. 
V Ørom, and R. M. Piro, “SPLICE-q: a Python tool for genome-wide quantification of splicing 
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Chapter I: Introduction 
Since the structure of DNA was discovered, the fields of cell and molecular biology 
have been trying to decipher how the information contained in this molecule is read by the 
cells. The biological instructions encoded by the DNA are carried by another nucleic acid, the 
RNA, which is generated through a process called transcription. The RNA undergoes a series 
of highly regulated post-transcriptional (or co-transcriptional) processing steps, including RNA 
splicing. Important findings regarding RNA splicing have demonstrated how this process is 
fundamental in the biology of the cell. Nevertheless, a vast field is yet to be explored 
concerning the dynamics of transcript processing. This chapter will introduce basic concepts 
of molecular biology focusing mainly on pre-mRNA splicing, its regulatory mechanisms, and 
how its misregulation impacts the functionality of the cell. Then, sequencing technologies - in 
particular, RNA sequencing - and its key applications will be described. Lastly, we show how 
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1.  The eukaryotic gene 
 Deoxyribonucleic acid (DNA) is a linear polymer carrying chemical information in the 
genetic code of all known cellular organisms and numerous viruses. The DNA is composed of 
monomeric units called nucleotides, each consisting of a phosphate group, a deoxyribose and 
a nitrogenous base. The DNA’s nitrogenous bases are the purines adenine and guanine, and the 
pyrimidines thymine and cytosine [1]. For convenience, the bases are commonly abbreviated 
as A, G, T, C, respectively. In 1953, Watson and Crick showed the purines binding to 
pyrimidine bases through hydrogen bonds allowing the construction of a stable double-helix: 
A preferentially binds to T via a double hydrogen bond while C binds to G via a triple bond  
(A=T; G≡C) [2]. Furthermore, the nucleotides are linked together by phosphodiester bonds 
established between the phosphate group and the C3 hydroxyl group of the adjacent nucleotide 
[1]. The sequence of nucleotides, also known as genetic information, carried by the DNA, 
encodes the instructions for growth, development, reproduction and more.  
 The term “gene” was first introduced in 1909 by Wilhelm Johannsen as a “unit of 
heredity” and its definition has been changing over the years. In the 1960s, it was defined as a 
continuous DNA sequence segment, encoding a polypeptide chain. Although it is still 
employed today, this definition is outdated. Most recently, the molecular concept of gene was 
redefined by Portin and Wilkins as [3]: 
“…a DNA sequence (whose component segments do not necessarily 
need to be physically contiguous) that specifies one or more 
sequence-related RNAs/proteins that are both evoked by GRNs 
[genetic regulatory networks] and participate as elements in 
GRNs, often with indirect effects, or as outputs of GRNs, the latter 
yielding more direct phenotypic effects.” 
 
The eukaryotic gene is characterized by a series of exons, intercalated by sequences 
with no coding potential called introns. During transcription, exons and introns are linearly 
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transcribed into a molecule of RNA (Box 1). Thereafter, the introns are excised in a process 
known as splicing [4]. The number of introns per gene varies greatly within a genome and 
when comparing genomes from different species. On average, a human gene has eight introns 
of approximately 3.300bp in length, while the exons are much shorter (mean of 245bp) [5].  A 
typical protein coding gene is illustrated in Figure 1A. Immediately upstream of the gene, near 
the transcription start site (TSS), lies the promoter, responsible for transcription initiation. The 
TSS is followed by the first exon which starts with a 5’ untranslated region (5’ UTR). Then, if 
the gene is not formed by just one exon, follows an alternating sequence of introns and exons. 
The last exon contains another untranslated region (3’ UTR). The UTRs are involved in many 
regulatory aspects of gene expression regulation.  
The intron structure is of 
particular interest to this thesis and it is 
highlighted in Figure 1B. The donor-site 
with consensus sequence GT (GU in the 
transcribed intron) at the 5’ region starts 
the intronic sequence. Close to the 3' end 
of the intron lies the branchpoint (BP), 
generally formed by a consensus 
YNCURAY. The BP includes an adenine 
nucleotide A involved in the lariat 
formation in the splicing reaction (see 
Section 4.3 for more details). A polypyrimidine tract is located downstream of the BP. This 
region consists of a sequence of 15-45 nucleotides. Lastly, there is the acceptor-site with 
consensus sequence AG at the 3’ end [6]. The donor-acceptor GT-AG consensus sequences are 
present in more than 95% of the introns in mammalian genomes [7]. 
Box 1 | Ribonucleic acid (RNA)  
Like DNA, RNA is a polymer of nucleotides 
carrying genetic information. The chemical 
structure of RNA, unlike the DNA, has a ribose 
as its sugar and the nitrogenous base uracil (U) 
replaces T. RNAs are mostly single-stranded, 
but they can assume various secondary and 
tertiary structures through internal bindings.  
Such as in DNA, all nucleotides have the same 
orientation (5'-P and 3'-OH). The RNAs are 
synthesized using a DNA segment as a template 
in a process called transcription. There are 
many types of RNAs, and they play numerous 
complex roles in the cells [1]. 




Figure 1: Structure of a protein coding gene. A) Main components of a eukaryotic gene. B) 
Representation of a transcribed intron. Y is a pyrimidine; N is any nucleotide; R is a purine and the 
branchpoint adenine (A) is in yellow. 
 
2.  From DNA to RNA: A short overview of DNA transcription 
 Transcription is the first step in gene expression, in which the information contained in 
a gene is used to form an RNA molecule. The messenger RNA (mRNA) which is a transcript 
of a protein-coding gene (PCG), for example, carries the necessary information to construct a 
protein or protein subunit1. Although the mRNA holds the same information as the gene, it is 
not an identical copy: Its sequence is complementary to the DNA template and the thymines are 








1 The following discussions focus on protein-coding genes, but similar considerations hold for non-coding genes. 
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Long noncoding RNAs: participate in numerous cellular regulatory 
processes, including transcription, translation and X-chromosome 
inactivation. >200nt in length. 
miRNA 
MicroRNAs: play a role in gene silencing of specific mRNAs and cause 
their degradation. ~22nt. 
mRNA 
Messenger RNAs: contain an open reading frame (ORF), i.e., a code for 
producing proteins. 
rRNA 
Ribosomal RNAs: form the ribosome, necessary for protein synthesis. 
Comprise ~ 80% of all RNA inside a cell. 
siRNA 
Small interfering RNAs: silence target mRNAs through degradation and 
rearrangements in chromatin structure. 20-25nt. 
snoRNA 
Small nucleolar RNAs: involved in the chemical modifications of rRNAs, 
tRNA and snRNAs. 
snRNA 
Small nuclear RNAs: participate in numerous nuclear processes, 
including pre-mRNA splicing. ~150nt. 
tRNA 
Transfer RNAs: participate in translation as adaptors linking mRNA and 
amino acids. 73-95nt. 
                      Ref: [4], [8] 
 
 The main enzyme responsible for transcription is called RNA polymerase (RNAP). 
Eukaryotes have different types of RNAP: RNAPI, RNAPII and RNAPIII. Although 
structurally similar, they transcribe different categories of genes. RNAPI and RNAPIII 
transcribe transfer and ribosomal RNAs as well as many small RNAs, while RNAPII is 
responsible for transcribing most genes, including all PCGs [7], [9]. Hence, transcription 
mediated by RNAPII will be our focus from now on.  
 RNAPII requires a group of transcription factors (TF), fundamental proteins with the 
ability to bind enhancer or promoter sequences to either stimulate or repress transcription. 
RNAPII can recognize and bind to specific sequences of DNA; separate the double helix to 
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expose the sequence of nucleotides to be transcribed; keep the DNA strands stably separated; 
maintain the DNA-RNA hybrid stable; and terminate the synthesis of RNA. The process 
catalyzed by this enzyme uses the single-stranded DNA as a template to synthesize the RNA 
molecule in the 5' to 3' direction through a reaction between the 3'-OH of a nucleotide and the 
5'-phosphate group of the nucleotide to be incorporated [4]. To maintain the accuracy of 
transcription, RNAPII must recognize initiation and termination sequence signals. The former 
is called promoter and the latter, terminator. A transcription cycle generally includes three 
stages [4], [9]: 
i. Initiation: This is a complex and highly regulated step where the DNA segment and 
RNAPII undergo numerous conformational changes. Many TFs assist RNAPII to bind 
to the promoter, near the TSS, to form the transcription initiation complex. The 
polymerase separates the DNA strands and the synthesis begins with its release from 
the promoter region. 
ii. Elongation: As transcription goes on, RNAPII uses the DNA strand template for base-
pairing through complementarity to form the RNA molecule. This step also includes a 
proofreading mechanism that replaces incorrectly incorporated nucleotides and is 
assisted by many elongation factors. 
iii. Termination: Sequences called terminators indicate that the transcript is fully 
transcribed and can be released from the RNAPII.  
3.  RNA secondary structure 
 One of the many properties of RNA molecules is the ability to form thermodynamically 
stable secondary structures in vivo and in vitro [10]. These structures vary and can directly 
regulate different mechanisms such as post-transcriptional modifications [11]. They can also 
be locally confined [12] or include hundreds of base pairs [13]. RNA structure is usually 
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described in terms of base pairing [14]. Some of the most common RNA secondary structure 
types are listed below and illustrated in Figure 2: 
 
Figure 2: Representation of RNA secondary structures. From [15]. 
 
Stem: This consists of a series of contiguous base pairs that form a flat structure, although 
there is a 360° rotation every 10 base pairs [14].  
Hairpin loop: This is the most common RNA secondary structure type, which is formed when 
two regions of the RNA strand with complementary sequences join through base pairing to 
constitute a double-stranded RNA ending in an unpaired loop. The stability of hairpin loops is 
determined by the length of the paired region as well as the loop, the number of mismatches in 
the paired region and the nucleotide composition [16]. 
Internal and external loops: The RNA can fold back on itself to shape different loops 
enclosed by stems. An internal loop happens when part of the stem is separated due to the 
impossibility to form base-pairs. Internal loops are divided into subgroups, like bulge loops  
[14], and can be distinguished from hairpin loops since the “looped out” regions occur in the 
middle of the stem. External loops are structures including both the 5' and 3' ends of the RNA 
sequence and do not have a closing base pair. They include at least one stem [17], [18]. Large 
RNA structures usually have many loops [14].  
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Multiloop: these more complex structures are formed by hairpin loops that may be separated 
by unpaired bases or not [14]. 
4.  Post-transcriptional modifications  
 The recently synthesized RNAs, or primary RNAs, need to go through some processing 
steps in order to produce mature RNA products. In this context, the precursor mRNA (pre-
mRNA) is a type of primary transcript which, after processing, becomes a messenger RNA 
(mRNA). The main post-transcriptional modifications are 5' capping, 3’ polyadenylation and 
splicing. On many occasions, they are tightly connected to transcription elongation and, for 
this reason, are also known as co-transcriptional modifications. This section will be focusing 
mostly on splicing. 
4.1  RNA capping 
 The 5ʹ-methyl cap is the first modification of pre-mRNAs in eukaryotes and some 
viruses. This 'cap' consists of modified guanine (m7G(5’)ppp(5’)X) and protects the new RNA 
molecule as soon as it emerges from the RNAPII complex [19]. This modification aids the cell 
in identifying different types of RNA. For instance, RNAPI and RNAPIII transcribe only 
uncapped RNAs. The 5ʹ-methyl cap plays a role in the nuclear export of the RNA, protection 
from exonuclease degradation, splicing and translation [4], [19]. 
4.2  3’-end formation: The poly(A) tail 
 As transcription is reaching its end, two important enzymes called cleavage stimulation 
factor (CstF) and cleavage and polyadenylation specificity factor (CPSF) recognize specific 
signals on the newly transcribed RNA for further processing. Once bound, other accessory 
proteins form the 3' end of the emerging mRNA. Then, after the RNA is separated from the 
RNAPII, the poly-A polymerase (PAP) acts by adding a tail of ~200 adenines at the recently 
cut 3' end. The mechanism by which the total length of this poly(A) tail is defined is poorly 
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understood, however, poly(A) binding proteins participate in this process [20]. Besides its role 
in the termination of transcription, the poly(A) tail protects the mRNA from degradation and 
participates in the molecule’s export from the nucleus and translation [21]. 
4.3  The landscape of splicing 
 Splicing was first described in the late 1970s through the observation that nuclear pre-
mRNAs were much longer than the mRNAs in the cytoplasm [22], [23]. As previously 
discussed, eukaryotic genes are mostly composed of a number of exons intercalated by introns 
that are removed from primary transcripts to form mature RNA molecules. This indispensable 
post-transcriptional process will be explored in the next sections.  
 
4.3.1  The biochemistry of splicing 
 Most 5 ́ and 3 ́ borders of an intron, also called splice junctions (SJ), contain consensus 
sequences, as previously shown in Figure 1B. During splicing, these regions are cut and the 
exons are joined through two transesterification reactions led by a large ribonucleoprotein 
Box 2 | Spliceosome: A dynamic machinery  
Pre-mRNA splicing is a complex process that requires a vast number of components.  The 
spliceosome's conformation and structure are highly dynamic, giving the splicing 
machinery efficiency and versatility at the same time. In eukaryotes, there are two 
different types of spliceosomes: the less abundant U12-dependent spliceosome which is 
responsible for the excision of U12-type introns (minor) and the U2-dependent 
spliceosome (major). The difference between both resides mostly in the specific snRNPs 
in their core. The minor spliceosome is composed of the snRNPs U11, U12, U4atac, 
U6atac and U5, and many other proteins. It processes introns characterized by their non-
canonical splice-sites. On the other hand, the major spliceosome comprises the snRNPs 
U1, U2, U4, U5, U6 besides many other auxiliary proteins. It is responsible for the 
removal of the introns containing the canonical GT and AG at the 5′ donor and 3′ acceptor 
sites, respectively [24], [25]. 
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complex called spliceosome (Box 2) [26]. This well-described large ribonucleoprotein (RNP) 
complex includes five small nuclear RNAs  (snRNA), which together recognize the SJs and 
the BP, forming the major spliceosome [27], [28].  
 
Figure 3: Transesterification reactions in the pre-mRNA splicing. A) Steps of the splicing reaction. 
The BP adenine (A, in red) attacks the donor site, cuts the 5ʹ-end of the intron and covalently binds to 
it, forming an intron lariat (shown in B). The free 3'-OH end of the 5' exon then reacts with the 
downstream exon and both are ligated. The intron lariat is released and recycled. From [4]. 
 
 Previous studies identified and described the two transesterification reactions (Figure 
3) that break or form the phosphodiester linkages that characterize splicing [29], [30]. In the 
first step, the donor site's G suffers a nucleophilic attack from the 2’ hydroxyl group present in 
the BP’s adenine’s pentose sugar, resulting in the formation of the intron lariat, i.e., the 2–5 
phosphodiester branched RNA intermediate. Consequently, this releases the 5’ exon from its 
previous junction with the intron. The second step consists of the 3' hydroxyl of the released 5' 
exon attacking the phosphate group of the first nucleotide downstream of the acceptor site. As 
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a result, the 5’ and now detached 3’ exon are joined, and the intron lariat is released, marking 
the end of splicing. The spliceosome is also responsible for the folding of introns that facilitates 
these reactions and for the precise recognition and pairing of the splice sites [24]. 
4.3.2  Small nuclear ribonucleoprotein particles 
 The small nuclear ribonucleoproteins (snRNPs) are essential components of the 
spliceosome and mediate the catalysis of pre-mRNA splicing. These RNA-protein complexes 
are formed from uridine-rich small nuclear RNA (non-coding RNA) and a wide collection of 
proteins (Figure 4). snRNPs are classified into two groups: Sm snRNAs and Sm-like snRNAs 
(Lsm). The former includes U1, U2, U4, U4atac, U5, U11 and U12 snRNAs, which present 
three essential recognition parts: a 5′-trimethylguanosine cap, an Sm-protein-binding site and 
a 3′ stem-loop structure. The second group is composed of U6 and U6atac snRNAs, containing 
5'-γ-monomethyl phosphate cap and a 3' stem-loop [31].  
 After transcription, Sm-snRNAs are exported to the cytoplasm in a process facilitated 
by an export machinery that subsequently disassociates from the pre-snRNA. Each snRNA 
associates with a set of seven Sm proteins (B/B′, D1, D2, D3, E, F and G) to form an extremely 
stable Sm core particle, essential for the stability of the snRNP. This step is carried out by the 
survival motor neuron (SMN) protein complex. Initially, the SMN complex binds to conserved 
regions in the snRNA. Then, the 5' cap is hypermethylated by trimethylguanosine synthase-1 
and the 3'-end is trimmed by an exonuclease. These modifications are necessary for the 
transport of the processed snRNP particle back into the nucleus where the Sm-class snRNPs 
are targeted to Cajal bodies for the next maturation steps. Finally, the newly produced snRNPs 
are stored in interchromatin granule clusters to be later used in pre-mRNA splicing [28], [31]. 




Figure 4: snRNP complexes. snRNA secondary structures and protein content of the major human 
spliceosomal snRNPs. From [28]. 
4.3.3  Spliceosome assembly and activity  
The conformation of the spliceosome is highly dynamic, offering both efficiency and 
functionality for the splicing machinery. As previously discussed, there are two different types 
of spliceosomes in Eukaryotes: the less abundant U12-dependent spliceosome which is 
responsible for the excision of U12-type introns and the U2-dependent spliceosome, 
responsible for the removal of 99% of the introns – the U2-type introns (Box 2). Each of the 
above-mentioned snRNPs (Section 4.3.2) forms complexes with many other specific proteins. 
U1, U2, U4 and U5 associate with a set of seven Sm proteins to form an extremely stable Sm 
core particle essential for the stability of the snRNP. The spliceosome carries out splicing 
throughout the steps illustrated in Figure 5.  




Figure 5: U2-type spliceosome assembly and activity. The snRNPs are represented by colored circles. 
Non-snRNPs participating in the processes are omitted. 5' and 3' exons are illustrated as light and dark 
blue boxes, respectively. Introns are displayed as a black line between the exons. The stages where 
DExH/D-box RNA ATPases/helicases Prp5, Sub2/UAP56, Prp28, Brr2, Prp2, Prp16, Prp22 and Prp43, 
or the GTPase Snu114, play a role facilitating the necessary conformational changes are indicated. The 
steps are shown counterclockwise. From [28]. 
 
 The first spliceosome cycle step consists of the formation of the E-complex. It begins 
with the U1 snRNP interacting with the 5 ́SJ of the intron through base pairing. The transacting 
factors called serine-arginine-rich (SR) proteins together form the 70kDa component of the 
U1snRNP and stabilize the protein-snRNA complex [32]. Also, SF1/BBP binds to the BP while 
the auxiliary factor U2 (U2AF) binds to the polypyrimidine tract downstream. U2AF’s larger 
subunit (65kDa) interacts with SF1/BBP and the smaller subunit (35kDa) binds to the acceptor 
site (AG consensus sequence). The pre-spliceosome, or A-Complex, is then formed through 
the base pairing of U2snRNP to the BP and displacement of SF1 [27]. Subsequently, the pre-
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assembled snRNP trimer containing U4/U6 and U5 snRNPs is recruited to form the B-complex 
(pre-catalytic spliceosome). Up to now, the spliceosome is still catalytically inactive. To enable 
the spliceosome to promote the first transesterification reaction, U1 and U4 must be released 
through numerous rearrangements involving RNA-RNA and RNA-protein interactions [33]. 
U2, U5 and U6 will then form a catalytically active B*-complex. Then, U6/U2 catalyzes the 
first reaction, forming the C-complex (catalytic spliceosome) [34]. At this stage occurs the 
release of the 5’end and the formation of the intron lariat. U2/U5/U6 remains ligated to the 
intron lariat and the C-complex undergoes additional rearrangements before the second 
reaction [35]. After this step, the DExD/H helicase Prp22 catalyzes the release of the mRNA 
and the U2, U5 and U6snRNPs are released and recycled to participate in other splicing cycles 
[36].  
 4.3.4  Alternative splicing: increasing the diversity of the proteome 
 Alternative splicing (AS) was first observed in the 1970s in adenovirus type 2 [22], 
[23]. Researchers observed that a single transcript was spliced in different ways, resulting in 
different proteins. Later, the first examples of alternative splicing were characterized in 
calcitonin and immunoglobulin genes [37], [38]. While in constitutive splicing the mRNA 
is always spliced in precisely the same way, AS is a process by which a single gene codes for 
different variants through exons being combined differently (Figure 6). Consequently, AS 
allows more products to be synthesized compared to the actual number of genes. This 
mechanism increases diversity between organisms, and it has been estimated that a range from 
35% to as high as 95% of human pre-mRNAs undergo alternative splicing [39], [40]. Different 
variants are generated through distinct mechanisms [41], [42]: 
 




Figure 6: Constitutive and alternative splicing. Boxes in red and blue represent constitutive and 
alternative segments (exons), respectively. Lines represent the introns. The grey box depicts a retained 
intron.  
 
Exon skipping: an event where an exon is spliced out (skipped) instead of being retained in 
the final transcript. These are known as cassette exons and this is the most frequent AS event 
in mammals.  
Alternative donor site: a type of AS where an alternative donor site is used, which shifts the 
upstream exon's 3’ boundary. 
Alternative acceptor site: a type of AS where an alternative acceptor site is used, which shifts 
the downstream exon's 5’ boundary. 
Mutually exclusive exons: an event where, after splicing, one of two exons is preserved in a 
mutually exclusive fashion, i.e., only one exon will be present in resulting mRNAs but not both 
in the same variant. 
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Intron retention: the least prevalent of the AS types in mammals, consists of the retention of 
an intronic sequence. The retained intron may then become part of the coding region which 
will often cause the production of a non-functional protein. A recent study showed how intron 
retention is connected to transcription and acts widely in the regulation of gene expression [43].   
 4.3.5  Crosstalk between transcription and splicing 
 Splicing is dynamic and occurs mostly during or immediately after the transcription of 
a complete intron. Co-transcriptional splicing was first suggested in D. melanogaster chorion 
genes using electron microscopy to observe the assembly of spliceosomes at the splice 
junctions in nascent transcripts [45]. Further, studies applying ChIP (chromatin 
immunoprecipitation, Box 3) revealed that the steps of the spliceosome assembly are similar 
to the way it is assembled in vitro in yeast and mammals, increasing evidence for the co-
transcriptional nature of splicing [46], 
[47]. In addition to these findings, further 
studies investigated introns that are co-
transcriptionally spliced. More recently, 
genome-wide studies in different cell 
lines and organisms using nascent RNA 
showed introns being spliced shortly after 
their transcription is finished: in S. 
cerevisiae, data revealed polymerase 
pausing at the terminal exon, permitting 
enough time for splicing to happen before 
the release of the mature RNA [48]; and analysis of nascent RNA also indicated that most 
introns in D. melanogaster are co-transcriptionally spliced [49], as well as in mouse [50] and 
many human cells and tissues [51]–[53]. Several other studies showed how splicing also 
Box 3 | Chromatin immunoprecipitation 
Chromatin immunoprecipitation, or simply 
ChIP, is an experimental approach commonly 
used to investigate the biological significance of 
DNA-protein interactions inside the cell. 
Through ChIP, DNA and the protein of interest 
are cross-linked and then the complexes are 
immunoprecipitated using antibodies that target 
the protein. Subsequently, the cross-link is 
reversed followed by purification of the ChIP-
enriched DNA. The DNA sequences associated 
with the precipitated protein can be further 
identified by other molecular biology techniques 
such as polymerase chain reaction (PCR) [44]. 
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interferes with transcription through different mechanisms involving, for example, SR proteins 
[54] and effects on chromatin [55], [56]. For further information, Oesterreich and colleagues 
have written an interesting and detailed review on co-transcriptional splicing [57]. 
 
 4.3.6  Defective pre-mRNA splicing 
 Since the overwhelming majority of human genes include introns, and up to 95% of 
human pre-mRNAs undergo AS, it is natural to think that disturbances of regular splicing may 
have negative consequences. Over 20 years ago, it was estimated that up to 15% of mutations 
that cause genetic disease affect pre-mRNA splicing [58]. However, this number is probably 
an underestimation as it only considers mutations in classical splice-site sequences. Indeed, 
mutations in other splicing regulatory sites can result in multiple outcomes, namely exon 
skipping, mutation-associated intron retention and introduction of pseudo-splice-sites. The last 
two events, in most cases, cause premature termination codons1 to be introduced, consequently 
resulting in degradation and loss of function [59]. 
 Naturally, since efficient pre-mRNA splicing is essential, its misregulation is related to 
numerous human diseases. For instance, Duchenne muscular dystrophy can be caused by a 
mutation in the DMD gene, which leads to the deficiency of the protein dystrophin. Therapies 
targeting the deleterious effects of these mutations through the modulation of dystrophin 
splicing were shown to be promising [60]. Furthermore, aberrant splicing in glioblastoma, an 
aggressive brain tumor, promotes the survival and proliferation of the cancerous cells. However, 
splicing-redirecting approaches and regulation of splicing factors could positively interfere 
with tumor development [61].  
 A lot of progress has been made towards the understanding of how splicing affects 
diseases and cancer biology together with an effort to understand how “splicing correction” 
approaches could be beneficial for therapy [60], [62], [63]. Yet, to better understand the 
dynamics of splicing and the perturbations that might be caused by aberrant transcript 
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processing, it is important to quantify splicing efficiency. These aspects will be discussed in 
the following sections. 
5.  Splicing kinetics: how to get there? 
 Understanding the splicing kinetics, i.e., how splicing events are coordinated and 
quantified is essential. The efficiency of splicing is commonly quantified by means of RT-
qPCR (Box 4) with primers that span exon-exon and exon-intron boundaries [65]. A strong 
signal obtained from the first is indicative that 
an intron has already been excised. On the 
other hand, strong signals from the later 
indicate transcripts from which the intron has 
not yet been spliced out. Yet, this 
methodology can only investigate a limited 
number of genes. By contrast, transcriptomics 
technologies, such as RNA-Seq, allow these 
analyses from a genome-wide point of view. 
Below, these technologies are summarized. 
 Although every cell in an organism 
contains the same genome, different cells and 
tissues will show a different expression 
profile. The transcriptome is the set and amount of RNA present in a cell, tissue or even an 
organism and represents its physiological state. Studying the transcriptome allows scientists to 
get a deeper understanding of the functional elements of the genome as well as its role in 
development, health and disease. Through high-throughput transcriptomics it is possible to 
Box 4 | Real-time quantitative reverse 
transcription PCR (RT-qPCR) 
RT-qPCR is a sensitive and powerful 
experimental approach for quantifying 
genetic material through the production of 
copies of a target sequence or genetic 
fragment. It involves the combination of 
cDNA reverse transcription and the 
amplification of the DNA targets through 
PCR to detect and measure, for example, the 
amount of specific RNA. This is possible 
since the amplification step is followed by 
the use of fluorescence [64]. RT-qPCR may 
be used in different ways such as the 
quantification of gene expression, 
transcription and splicing kinetics, and in 
clinical settings. 
__________________________________________________________________________________________________________________________________________ 
1 A codon is a nucleotide triplet which encodes for an amino acid, except for a termination or stop codon which 
act as termination sites, indicating the end of the protein-coding sequence [4]. 
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identify most - if not all – mRNAs, non-coding RNAs and small RNAs; investigate gene 
structures, e.g. TSS, 5’ and 3’ ends, the number of exons and introns, splicing patterns; and 
quantify expression levels [66]. Over the years, different technologies for analyzing the 
transcriptome have been developed. When it comes to quantifying splicing efficiency, RNA 
Sequencing (RNA-Seq) stands out. This technology is described in more detail in Box 5. 
5.1  Experimental tracing of splicing kinetics  
 From the splicing efficiency perspective, RNA-Seq allows us, for example, to assess 
nascent transcripts before introns have been totally spliced out—i. e., within short intervals of 
time after the transcription has started [67]. Experimentally, this can be achieved through 
metabolic labeling with uridine (U) analogs such as 4-thiouridine (4sU), 5-etyniluridine (EU) 
and 5′-bromo-uridine (BrU) over a time course [68]. Shortly, this method consists of exposing 
the RNAPII to one of these labeled compounds (pulse step) that is used in the synthesis of new 
RNA transcripts for a short, well-defined period. Next, the unlabeled substance (here, normal 
uridine) is added (chase step) and the production of RNA continues, but without the labeled 
compound from the pulse phase. Lastly, the labeled RNAs are isolated and prepared for 
sequencing [69], [70]. This type of assay is also called pulse-chase analysis and it can provide 
information concerning RNA transcription and the primary transcript processing that occurred 
during the chosen labeling period. In addition, incorporating the chase step in time points 
allows the investigation of the fate of the nascent RNA over time as well as its processing [71]. 
 Barrass and colleagues [72], for example, took advantage of this approach to investigate 
the kinetics of RNA processing. Focusing specially on splicing, and using labeling times as 
short as 1.5 minutes, they studied short-lived non-coding RNAs as well as intron-containing 
pre-mRNAs in Saccharomyces cerevisiae. Through metabolic labeling, they were able to 
assess nascent transcription and revealed the significant association between non-coding RNA  
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Box 5 | RNA Sequencing (RNA-Seq) 
RNA-Seq uses next-generation sequencing technologies and provides a relatively accurate 
measurement of transcript levels. Since the first reports using this technology were published 
[73]–[75], multiple advances have been made towards the understanding of eukaryotic 
transcriptomes. Briefly, the total or a fraction of an RNA population is first transformed into 
a fragmented cDNA library through RNA or DNA fragmentation. Then, adaptors are linked 
to the ends of the cDNA fragments. Millions of molecules are sequenced at the same time to 
acquire short sequences from one or both ends (single-end and paired-end sequencing, 
respectively) (Figure 7). The resulting sequencing read length varies from 30 to 400 base 
pairs according to the sequencing technology applied [66]. These reads are further aligned to 
a reference genome or transcriptome and used for many purposes. 
 
Figure 7: Standard RNA-Seq protocol. Steps of an RNA-Seq experiment from library construction 
to gene expression profile. Adaptors are illustrated in blue and orange. A yeast open reading frame 
(ORF) containing one intron is shown in light blue. Mapped sequencing reads are represented in light 
grey and splicing reads (or junction reads), in yellow. From [66]. 
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length, secondary structures and stability – findings that would not have been possible in wild-
type cells at steady state.   
 Another way to assess nascent transcripts is through the purification of chromatin-
associated nascent RNAs. In this approach, the cells are biochemically fractionated before 
RNA isolation, enabling the analysis of the different steps in the lifetime of RNA molecules 
[76].   
5.2  Measurement of splicing efficiency using RNA-Seq reads 
For intron-containing transcripts, splicing efficiency can be determined with different 
frameworks that use read counts on intronic and exonic regions. In other words, an RNA-Seq 
experiment can function as a "snapshot" of the RNA while splicing is still ongoing with the 
splicing efficiency being the fraction of molecules that have already been spliced. Short-read 
RNA-Seq is currently the main approach using either nascent or total RNA.  
Conceptually, splicing efficiency can be observed either from an intron-centric point of 
view—to investigate whether an intron has been spliced out—or from an exon-centric point of 
view—to investigate whether an exon has been correctly spliced within the context of its 
transcript.  
Khodor et al. [49] used an intron-centric method to estimate the unspliced fraction of 
introns in D. melanogaster by taking the ratio of the read coverage of the last 25 bp of an intron 
and the first 25 bp of the following exon. In this way, introns, where the RNA polymerase has 
not yet reached the acceptor splice site, are not included but the metric is not guaranteed to take 
values between 0 and 1 and does hence not constitute an efficiency metric in the strict sense. 
Tilgner et al. [52] used deep-sequencing of human subcellular fractions and developed an exon-
centric “completed splicing index” (coSI) which takes reads spanning the 5’ and the 3’ splice 
junctions of an exon and computes the fraction of reads indicating completed splicing, i.e., 
which span from exon to exon, to study co-transcriptional splicing. By explicitly considering 
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also reads which span from the upstream exon directly to the downstream exon, this approach 
includes exon skipping events, but coSI values for the first and last exon of a transcript cannot 
be determined. More recently, Převorovský et al. [77] presented a workflow for genome-wide 
determination of intron-centric splicing efficiency in yeast. The efficiencies are quantified for 
the 5’ and 3’ splice junctions separately as the number of “transreads” (split reads spanning 
from exon to exon) divided by the number of reads covering the first or last base of the intron, 
respectively. Although the authors call their metric “splicing efficiency”, it is not limited to a 
range from 0 to 1 and it is not clear how cases without intronic reads (divisions by zero) are 
handled. Other drawbacks of this workflow are that it consists of numerous open-source tools 
and custom shell and R scripts and that it was explicitly developed for yeast.  
6.  Objectives and Significance  
Although the above-mentioned frameworks for calculating splicing efficiency from 
RNA-Seq data exist, there is more to add to their respective limitations. The bioinformatics 
steps involved might be challenging - including difficulties in running workflows that require 
long running times and the installation of numerous tools - specially for experimental 
biologists. Thus, we present here a user-friendly open-source Python tool for genome-wide 
quantification of splicing efficiencies. 
 The objectives of the present work include: (i) Implement a complete and user-friendly 
tool for genome-wide quantification of splicing efficiencies from RNA-Seq data. (ii) Provide 
an in-depth study that addresses different temporal splicing patterns and their underlying 
biological features using time-course nascent RNA-Seq data. These features include gene and 
intron length, gene and intron nucleotide composition (GC content), gene expression levels, 
gene biotype, gene function and intron ordinal position. Search for common motifs at splice 
junctions to look for relevant regulatory elements influencing the splicing dynamics. Also, 
analyze the RNA secondary structure elements and their RBP binding preferences. 
Chapter 1: Introduction 
24 
 
 Focus on splicing efficiency measurement using the newest and the most efficient 
methods is important for understanding the impact of its regulation. It is also a contribution to 
a global understanding of many biological processes in multiple organisms, including 
mechanisms behind numerous human diseases. This project will certainly align with 
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1.  Cell culture and metabolic labeling 
To assess nascent transcripts before introns have been totally spliced out, quantify 
splicing efficiency and later explore the dynamics of pre-mRNA splicing, we used BrU-Seq 
data. The cell culture and metabolic labeling prior to the RNA-Seq (BrU-Seq) used in this study 
were performed by our collaborators as described in more detail in [70], [78].  
Shortly, HEK293 cells were cultivated in DMEN growth medium supplemented with 
10% fetal bovine serum (FBS) at 37°C and 5% CO2. One day before the BrU labeling, 
approximately 2 million cells were seeded in 100mm plates containing 10ml media. For each 
time point, one plate was used. A BrU (5-bromouridine, Santa Cruz Biotechnology catalog 
number CAS 957-75-5) final concentration of 2mM was added to the medium and the cells 
were incubated for 15 min (pulse). Cells were then washed three times in PBS and either 
immediately collected (0 minutes chase) or chased for 15, 30 and 60 minutes in conditional 
medium supplemented with 20mM uridine (Sigma cat. no U3750-25G). RNA was purified 
using TRIzol following the manufacturer’s instructions. RNA quality was analyzed using 
Agilent 2100 Bioanalyzer with an Agilent RNA 6000 Pico kit according to the manufacturer’s 
instructions (Figure 1). 
 
Figure 1: Cell culture 
and metabolic labeling: 
Workflow for RNA pulse-
labeling with BrU and 
chase to follow nascent 
RNA (modified from 
[70]). 
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1.1  RNA-Seq data processing and QC 
The library was prepared with TrueSeq Stranded Total RNA Kit (Illumina). Sequencing 
was performed on Illumina HiSeq 2500 to obtain an average of ~200 million read pairs per 
sample. The strand-specific reads were mapped to GRCh38.p10 with STAR v2.7.1a [79] 
according to recommendations from the STAR manual 2.4.0.1. The index was built on gencode 
v27 (ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release27/gencode.v27.anno 
tation.gtf.gz). The GEO [80] accession numbers for these sequencings are GEO: GSE92565 
and GSE83561. 
FastQC [81] was used for quality control on the raw sequence data. This tool provides 
a simple and quick quality control (QC) summary on raw sequencing data, imported as BAM, 
SAM or Fastq files. The results are shown as modular graphs and tables that track data issues 
that should be addressed before further analysis. The modules of FastQC include basic statistics 
such as read counts and length, sequence quality and content, GC content bias, read length 
distribution, duplication levels, overrepresented sequences and adapter and k-mer content. 
Each issue should be addressed with caution while taking into consideration the context of 
what is expected from the library. For the present samples and type of sequencing, there were 
no problematic issues.  
DeepTools2.0 [82] was used to assess genome-wide similarity of the sequencing 
replicates. This is computed by correlating the read coverages in consecutive bins of 10 
kilobases in all samples. Replicates are highly correlated with an average ρ = 0.95 which fits 
the ENCODE consortium recommendations for biological replicates [83].  
2.  Other datasets 
The other datasets processed and analyzed in this thesis are described in Table 1.  
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HEK293 cells labeled with uridine analog 4-tU for 0 
(total), 7.5, 15, 30, 45, and 60 minutes and collected 




S. cerevisiae labeled with 4tU labeling for 1.5, 2.5 
and 5 minutes. Total RNA-Seq was also performed. 
All experiments were performed in triplicate. 





Total RNA from fresh frozen prostate cancer tissue 
along with a matched normal control sample. Patient 






HNEK cell compartments data Poly(A) and 
nonPoly(A) selected. Sequenced on Illumina 
Genome Analyzer II. 
 
3.  Clustering 
As part of the analysis performed in the second part of this thesis (Chapter IV), we used 
splicing efficiency values quantified from the BrU-seq data (described at the beginning of this 
chapter) to group introns.  
3.1  K-means 
K-means clustering was computed with R function kmeans with k = 70 and nstart = 
100. K-means [87] is an unsupervised learning algorithm, i.e., the algorithm cannot predict 
results and simply tries to find trends in the data. The number of clusters must be determined 
beforehand. Each observation is randomly allocated to a cluster, and the centroid of each cluster 
is determined. The algorithm iterates through the following steps [88]: 
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i. Assign each observation to the clusters (k). 
ii. Identify the centroid (mean point) of each cluster. 
iii. Compute the distances of the centroids from each data point and place it into the cluster 
with the minimum distance from the centroid. 
iv. Compute the centroid of the new cluster found and repeat the steps until the minimum 
within-cluster variation is reached. This variation is computed as the least squared 
Euclidean distance between each point and the centroid of the cluster it belongs to. 
3.2  Hierarchical clustering 
To get the previously generated clusters into groups assigned according to intron 
splicing dynamics (fast, intermediate and slow), Agglomerative Hierarchical Clustering (AHC) 
was computed using the centroids of the 70 clusters. In short, AHC assigns each observation 
to a cluster, then the distance between each cluster is computed and the two closest clusters are 
merged. The steps are repeated until there is only one cluster, i.e., the clusters can be formed 
following a hierarchy - from bottom to top or vice-versa [88].  
The R function agnes was chosen due to the agglomerative coefficient (AC) it provides. 
This value varies from 0 to 1 and measures the cluster structure, thus allowing for the best 
method to be chosen. An AC closer to 1 suggests a strong cluster structure. Ward’s method 
was chosen, and the resulting cluster was represented as a dendrogram. Ward's method aims at 
reducing the overall within-cluster variance by merging clusters with minimum between-
cluster distances at each step combined with minimum information loss [88], [89]. 
4.  Gene type annotation 
Gene types from the genes present in this study were retrieved from BiomaRt [90], [91]. 
The Protein Coding Gene (PCG), Pseudogene and Long Non-coding RNA (lncRNA) 
categories were defined as described in Table 2. 
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5.  Gene expression quantification 
RNA-Seq transcript expression was quantified against the GRCh38.p10 genome using 
the bioinformatic tool Salmon [53]. First, the gene annotation file version gencode v27 was 
downloaded from the Gencode database. Then, the mapIds R function was used to create a 
database that maps transcripts to genes according to the reference. Next, Salmon quantification 
files (“quant.sf”) were generated containing the number of reads and the number of transcripts 
per million (TPM) of each transcript, and the tximport R package was used to import counts 
and aggregate the transcript abundance at the gene level. Finally, counts were normalized using 
TMM (trimmed mean of M values) from edgeR package [92]. TMM normalization is a method 
that measures relative RNA production levels by assuming that most genes are not 
differentially expressed and adjusts the library sizes accordingly. To keep only expressed 
genes, CPM (Counts per Million) values were calculated for each gene. The CPM calculation 
considers the effective library sizes previously calculated by the TMM normalization. 
Following, a second round of normalization is performed across the samples for each gene. 
Here, the individual gene counts are mean-centered and scaled to unit variance. Lastly, the 
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counts were voom transformed (limma package [93]). Shortly, Voom is an approach that 
robustly and non-parametrically estimates the mean-variance relaionhsip of the log-counts 
normalized for sequence depth (log-cpm). Then, as a function of average log-count, the mean-
variance trend is incorporated into a precision weight for each normalized observation 
individually [94].  
6.  Motif enrichment analysis (MEA) 
6.1  Transcription start sites (TSS) 
To evaluate how transcription factors and other DNA binding proteins influence the 
splicing dynamics, we first applied HOMER’s (Hypergeometric Optimization of Motif 
EnRichment) [95] findMotifs.pl which analyzes promoter sequences and searches for motifs 
that are enriched in the target sequences relative to others (background). The input is a list of 
gene identifiers such as Ensembl gene ID, Entrez gene ID, Refseq, etc. Ensembl gene IDs were 
provided, and motifs of length 8 to 20 nucleotides were searched from -400 to +100 relative to 
each gene’s TSS. The HOMER differential motif discovery algorithm applies zero or one 
occurrence per sequence scoring (ZOOPS) together with hypergeometric enrichment 
calculations (or binomial) to define motif enrichment significance. findMotifs.pl operates 
according to the following steps:  
i. Converts the gene accession numbers provided as input to a consistent gene identifier 
(Entrez gene ID). 
ii. Selects a meaningful background. 
iii. Performs Gene Ontology (GO) enrichment quantification of various categories of gene 
function, biological pathways, domain structure, chromosome location, etc. The GO 
enrichment assumes a hypergeometric distribution. 
iv. Assigns weights to background sequences according to the CpG distribution in the 
targets in a way that comparable numbers of low and high-CpG sequences are analyzed. 
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v. Performs de novo motif analysis. HOMER searches for motifs that are over-represented 
in the target sequences (input) relative to the background using the cumulative 
hypergeometric distribution (or cumulative binomial distribution for large data sets). 
Motifs are first found by exhaustively checking for simple motif enrichment and later 
refining the best candidates into accurate probability matrices. 
vi. Generates an HTML output for the de novo analysis containing non-redundant motifs 
sorted by p-value. 
vii. Performs motif enrichment analysis of known motifs and generated the HTML output 
file. The "known motifs" are derived from published ChIP-seq data. 
 
6.2  RNA-binding proteins (RBPs)  
The MEME suite’s v5.1.1 [96] Analysis of Motif Enrichment (AME) program [97], 
was used with default parameters to identify known enriched RPB motifs. AME uses a 
parameter-free linear regression method to identify biological patterns within the nucleotide 
sequences. In other words, the user is not required to select a threshold on the biological signal 
for partitioning the genes into negative or positive sets. The groups of introns defined as Fast 
and Slow splicing generated through clustering (section 3 of this chapter) were used as control 
and background of one another. The input should contain sequences in FASTA format which 
we extracted using getfasta from Bedtools 2.27.0 [98]. AME detects known motifs provided 
by the user which are comparatively enriched in the input sequences compared to control 
sequences. For this, we chose the RNA-binding motifs available at [99]. Furthermore, AME 
scores a series of sequences with a motif, treating each sequence as a possible match for the 
pattern. Numerous types of sequence scoring functions are supported, and the motif 
occurrences are handled equally, i.e., regardless of their locations in the sequence . We used 
the average odds score (default) in which the average PWM (position weight matrix) motif 
score of the sequence is used. The statistical test used for testing motif enrichment was one-
tailed Fisher's exact test. The output is an HTML file containing only significantly enriched 
motifs. 
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6.2.1  Splicing factors 
 AME was also applied to search specifically for splicing factors (SF) within introns and 
splice junction regions (Table 3).   














7.  Analysis of splice site strength 
 5’ and 3’ end strength, or simply how "strong" splicing signals are in terms of 
conservation, was quantified with MaxEntScan 0.0.1 [105]. In short, this tool is based on the 
maximum entropy principle that generalizes probabilistic models generally used in MEA. 
MaxEntScan scores a 9-mer (5' splice site) and a 23-mer (3' splice site) against the consensus 
sequence that is built from all splice sites. The 5’ side (donor) comprises 3 exonic and 6 intronic 
bases while the 3’ side (acceptor) has 3 exonic and 20 intronic bases. These intervals should 


























































































1 IUPAC nucleotide code - A: Adenine; C: Cytosine; G: Guanine; U: Uracil; R: A or G; Y: C or T; S: G or C; W: 
A or T; K: G or T; M: A or C; D: A or G or T; H: A or C or T; V: A or C or G; N: any base [185], [186]. 
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upstream of the 3' splice site, respectively. A high score should mean a high similarity between 
the input and the consensus sequence, i.e., a “strong” splice site.  
 
8.  RBP preferences for secondary structure 
Knowing that RBPs recognize both sequence and structure aspects in their binding sites, 
RBPmotif [106] was applied to predict sequence (de novo motif search) and stable secondary 
structure binding preferences of RBPs in a 100bp window around the splice junctions – 
allowing us to investigate if RNA secondary structure preferences differ according to the speed 
of splicing. The secondary structure prediction uses RNAplfold. This algorithm computes local 
pair probabilities for base pairs. Briefly, this algorithm considers the collection of all potential 
RNA sequence structures to quantify probabilities in various structural contexts for each base. 
The type of secondary structure representation chosen was PHIME which has different 
structural contexts: paired (P), hairpin loop (H), internal loop (I), multiloop (M), external loop 
(E). These structures are described in more detail in Chapter I. A “secondary structure profile” 
matrix is computed, and each entry represents the probability of a base to be present in a given 
structural context. Parameters of the secondary structure are weighted so that the most desired 











































We have previously described the frameworks available to quantify splicing efficiency 
from RNA-Seq data. However, the bioinformatics steps involved to reach the quantifications 
might be challenging, specially for experimental biologists as they would include numerous 
tool installations and long running times. Aiming to overcome these challenges, this chapter 
will introduce the approach used to develop SPLICE-q, an up-to-date and user-friendly tool for 
























1.  SPLICE-q 
SPLICE-q is a tool implemented in Python 3 for quantification of individual intron 
splicing efficiency from strand-specific RNA-Seq data. SPLICE-q's main quantification 
method uses splicing reads – both split and unsplit – spanning the splice junctions of a given 
intron (Figure 1). Split reads are junction reads spanning from one exon to another, thus 
indicating processed transcripts from which the individual intron has already been excised. 
Intuitively, unsplit reads are those spanning the intron-exon boundaries (covering both sides of 
the splice junction), hence, indicating transcripts from which the intron has not yet been spliced 
out. As an alternative measure for splicing efficiency, SPLICE-q computes an inverse intron 
expression ratio (IER), which compares the introns’ expression levels with those of their 
flanking exons. 
 
Figure 1: Read assignment scheme for splicing efficiency (SE) and inverse intron expression ratio 
(IER).  Illustration of the reads used by SPLICE-q to quantify SE and IER. In yellow, split reads at the 
5’ splice junction; in orange, split reads at the 3’ splice junction; in green, unsplit reads at the 5’ splice 
junction; in dark blue, unsplit reads at the 3’ splice junction. In gray and blue, the areas covering the 
exons and introns, respectively. In white, reads not overlapping splice junctions.  
 
1.1  Quantifying splicing efficiency and inverse intron expression ratio 
Splicing efficiency (SE): SPLICE-q uses split and unsplit junction reads to quantify SE 
for each intron individually. It determines the RNA-Seq reads mapping to both splice junctions 
of an intron, distinguishes split and unsplit reads for the 5’ and 3’ splice junctions of this intron 




and estimates a splicing efficiency score (SEi) as a function of the corresponding read counts 










     0 ≤ 𝑆𝐸𝑖 ≤ 1                   (Eq.1) 
Where S and N are the numbers of split and unsplit reads, respectively, which map to the 5’-
end (5′) and 3’-end (3′) splice junction of a given intron i.   
An SE of 0 indicates that the intron has not been spliced out in any of the transcripts 
from which the junction reads originate, which may be due to late splicing in the case of nascent 
RNA-Seq or intron retention in the case of steady-state RNA-Seq. An SE of 1 means completed 
splicing on all transcripts. Therefore, SE values ranging between 0 and 1 approximate the 
fraction of molecules that have already been spliced. This quantification method makes it 
possible to compare spliced and unspliced intron rates directly.  
Inverse intron expression ratio (IER): as an alternative measure for splicing 
efficiency when using Level 3 filtering, SPLICE-q also provides the inverse of the ratio of 
intron expression to exon expression, where Ix is the median per-base read coverage of the x-
th intron of a given transcript  and Ex and Ex+1 represent the corresponding median coverages 
of the flanking exons:  
𝐼𝐸𝑅 = 1 −min (1,
Ix
0.5∙(Ex+Ex+1)
)  0 ≤ 𝐼𝐸𝑅 ≤ 1                  (Eq.2) 
Here, the focus lies specifically on the per-base median coverage of all reads mapping 
to the involved genomic elements (exonic and intronic reads) rather than just the splice 
junctions (Figure 1). As explained above, a high SE indicates that an intron was spliced out of 
a large fraction of transcripts. This scenario should display high read coverage in the exons and 




low coverage or none in the intron. In other words, peaks of mapped reads are observed in the 
surrounding exons when compared to the intron itself. On the contrary, introns with a low SE 
should have read coverage profiles more similar to the surrounding exons.  
1.2  Workflow and parameters 
SPLICE-q is also sensitive to the overlap of genomic elements. In other words, 
SPLICE-q takes into consideration when a genome shows overlapping features that can cause 
issues with a correct assignment of reads to specific introns or exons. For example, for intron-
exon boundaries overlapping exons of other genes, seemingly unsplit reads might instead stem 
from exonic regions of the overlapping genes. This is problematic due to the RNA-Seq 
methodology’s limitation that makes it difficult to confidently determine without ambiguity to 
which genomic element, exon or intron, these reads should be attributed [107].  
Therefore, SPLICE-q allows the user to select different levels of restrictiveness for 
strand-specific filtering, including (i) Level 1: keep all introns in the genome regardless of 
overlaps with other genomic elements; (ii) Level 2: select only introns whose splice junctions 
do not overlap any exon in different genes; (iii) Level 3: select only introns that do not overlap 
with any exon of the same or different genes (Figure 2). The two necessary input files are:  
i. A Binary Alignment Map (BAM) file, which is simply the binary version of a Sequence 
Aligned Map (SAM) file. Sequence alignment tools, such as STAR [79], provide BAM 
files as output and, in other cases, the conversion from SAM to BAM can be easily achieved 
with Samtools [108].  
ii. A genome annotation file provided by GENCODE [109] or Ensembl [110] in Gene 
Transfer Format (GTF) containing information on exons and the genes and transcripts they 
are associated with. 
 





Figure 2: SPLICE-q’s levels of restrictiveness. (Level 1) keep all introns in the genome regardless of 
overlaps with other genomic elements; (Level 2) select only introns whose splice junctions do not 
overlap any exon in different genes; (Level 3) select only introns that do not overlap with any exon of 
the same or different genes. A and A.1 are isoforms of the same gene (A) and B represents a different 
gene.  
 
SPLICE-q’s internal default workflow comprises of the following major steps (Figure 3):  
i. Parsing of genomic features from the GTF file; 
ii. Locating and annotating introns and splice junctions from the GTF’s exon coordinates; 
iii. Filtering of introns according to the level of restrictiveness based on the overlap of 
genomic elements;  
iv. The selection of split and unsplit reads at the splice junctions according to the reads’ 
concise idiosyncratic gapped alignment report (CIGAR), and subsequent coverage 
calculation for each individual splice junction. 
v. Computation of splicing efficiencies (SE). 
For Level 3 filtering, when the user chooses to include the inverse intron expression ratio, the 
workflow includes the following steps (Figure 4):  
i. Parsing of genomic features from the GTF; 
ii. Locating and annotating exons, introns and splice junctions.  
iii. Filtering of introns that do not overlap with any exon of the same or different genes;  
iv. Computation of median per-base coverages of introns and their flanking exons  
v. Computation of the inverse intron expression ratios (IER). 





Figure 3: SPLICE-q’s default workflow. Dashed lines indicated steps that depend on parameter 
settings. Solid lines represent the mandatory steps of the workflow. A BAM index (.bai) file is generated 
if not provided by the user (yellow). Arrows in blue represent a lookup in the data structure they pass 
through. SJ = splice junction; TSV = tab-separated vector. 





Figure 4: SPLICE-q’s inverse intron expression ratio workflow. Dashed lines indicate steps 
where parameters can be set up. Solid lines represent the mandatory steps of the workflow. The 
generation of an index (.bai) file is mandatory if not provided by the user (yellow). Arrows in blue 
represent a lookup in the data structure they pass through. I = Introns, E = Exons, SJ = splice junctions. 
The standard output is a 14-column tab-separated values (TSV) file containing: 
chromosome, strand, ensemble gene stable ID, ensemble transcript stable ID, intron number, 
SJ5’ start position, SJ5’ end position, SJ5’ split read count,  SJ5’ unsplit read count, SJ3’ start 
position, SJ3’ end position, SJ3’ split read count,  SJ3’ unsplit read count, SE score. When 




running with the inverse intron expression ratio option, the program outputs a 15-column TSV 
consisting of chromosome, strand, ensemble gene stable ID, ensemble transcript stable ID, 
intron number, intron start position, intron end position, 5’ exon median coverage, SJ5’ split 
read count,  SJ5’ unsplit read count, intron median coverage, SJ3’ split read count,  SJ3’ unsplit 
read count, SE score and IER. SPLICE-q’s default will only count reads with unique alignment, 
but the user can choose whether to include reads aligned to multiple places in the genome 
according to mapping quality scores. Other filters can also be set up according to users’ 
requirements (Table 1).  
Table 1:  Summary table of parameters. 
Parameter Description 
MinCoverage 
Minimum number of reads spanning each splice junction (Default = 
10). 
MinReadQuality 
Mapping quality. By default, only uniquely mapped reads are included 
(Default = 10). 
MinIntronLength 
Minimum intron length. Default value is optimal for analysis using 
human RNA-Seq data (Default = 30) [111]. 
FilterLevel 
(1) keep all introns in the genome regardless of overlaps with other 
genomic elements. 
(2) select only introns whose SJs do not overlap any exon in different 
genes 
(3) select only introns that do not overlap with any exon of the same 
or different gene (Default). 
EIRatio 
Running mode that additionally outputs exonic and intronic coverage 
ratio. Restricted by FilterLevel.  
NProcesses 
Multiple concurrent processes are used to minimize running times and 
the number of processes can be adjusted by the user through this 









1.3  Compatibility and requirements 
SPLICE-q requires pysam (https://github.com/pysam-developers/pysam) and uses 
modified functions from GTFtools [112]. The efficient data structure for working with 
intervals and checking for genomic overlaps is provided by the InterLap module 
(https://github.com/brentp/interlap). Due to pysam’s requirements, SPLICE-q is limited to 
macOS and Linux platforms but can be run on Windows 10 through its subsystem for Linux. 
1.4   Fast and user-friendly quantification of splicing efficiency 
SPLICE-q’s run time with default parameters for approximately 100 million input reads 
mapped to the human genome is 18 minutes using a MacBook Pro with a Dual-Core Intel Core 
i5 processor and 8GB of RAM. By increasing the number of processes to 4 or 8, which is not 
an issue considering nowadays’ number of processor cores of most laptops and desktops, the 
running time on an AMD Opteron 6282 SE with 516GB of memory is less than 2 minutes 
(Figure 5a). Memory usage is low, being approximately that of the GTF file size (1.4 GB for 
the human genome; Figure 5b). SPLICE-q’s approach provides major advantages over 
previous workflows which may require the installation of numerous tools and suffer from long 



















Figure 5: SPLICE-q’s run time and memory usage. a) Run time for approximately 100 million input 




















































Chapter IV: Splicing Kinetics 




Results: SPLICE-q Application 
In Chapter III, we introduced the approach used to develop SPLICE-q, a tool for 
SPLICing Efficiency quantification.  Understanding the splicing kinetics, i.e., how splicing 
events are coordinated and quantified is essential. Thus, in this Chapter, we show the usefulness 




















1.  Splicing kinetics in human and yeast 
We applied SPLICE-q to globally assess the kinetics of intron excision. The goal here 
is to show the tool’s applicability using different data. For this purpose, we performed three 
different analyses using data from two species and different methodologies (Chapter II, Table 
1). The first set of sequencing data is a strand-specific paired-end nascent and total RNA-Seq 
of human embryonic kidney cells (HEK293). Cells were progressively labeled with 4SU for 
7.5, 15, 30, 45 and 60 minutes before the RNA was purified (nascent RNA) [84]. There was an 
average number of ~31 million uniquely mapped read pairs per sample. SPLICE-q was applied 
with default parameters: filtering level 3, minimum coverage of 10 uniquely mapped reads at 
each splice junction and minimum intron length of 30 nucleotides. Only introns satisfying the 
filtering criteria in all samples after running SPLICE-q were kept, totaling ~10k introns. As 
expected, SPLICE-q detects a progressive increase of SE throughout the time course (Figure 
1a). Interestingly, at 7 Minutes, the SE scores are already high with a median of 0.65. This 
agrees with previous studies showing that splicing is predominantly co-transcriptional in 
humans and for the most part happens immediately after the transcription of an intron is 
completed, when the RNA polymerase has proceeded only a few bases into the downstream 
exon [45], [48], [51]–[53]. However, this value remains almost unchanged until the next time 
point (Figure 1a), when it starts to increase again, gradually approaching the level at steady 
state (total RNA): medians of 0.85 and 0.96 for the 60 minutes and total RNA sample, 
respectively.  
We chose a second dataset [85] which would allow us to quantify the splicing efficiency 
of nascent RNA within a finer time scale. These sequencing experiments were performed with 
4-thiouracil labeled RNA (4tU-seq) from Saccharomyces cerevisiae. Nascent RNA was 
labeled for an extremely short time (1.5, 2.5 and 5 Minutes) and then sequenced [85] (Figure 
1b). Unlabeled control samples were also generated. After alignment of the raw data, we 




obtained an average of over 50 million uniquely mapped reads per sample and 246 introns – 




Figure 1: Splicing kinetics using different datasets. a) Time-series nascent and total RNA-Seq of 
HEK293 cells; b) Time-series nascent and total RNA-Seq of S. cerevisiae; and c) RNA-Seq of human 






















total of 296 introns present in yeast [113] – shared between all samples after running SPLICE-
q with the above-mentioned default parameters and filtering level 2. The SE at 1.5 minutes has 
a median of 0.29 while, strikingly, there is an increase of 131% in just one minute, with a 
median SE of 0.67 at 2.5 minutes. This value does not alter in the next time point and the 
unlabeled control sample shows a median SE of 0.93. This brief analysis suggests how essential 
it is to perform short labeling in S. cerevisiae in order to assess its splicing kinetics since some 
transcripts approximate steady-state levels in a time as short as 2.5 minutes.  
The next dataset consists of deep sequencing of subcellular RNA fractions in human 
immortalized myelogenous leukemia cells K562 [52]. The data include poly(A)- and poly(A)+ 
chromatin-associated total RNA and nuclear RNA, and cytosolic RNA. This approach allowed 
SPLICE-q to assess the SE scores of introns in different levels of RNA processing in the cell 
(Figure 1c). There was an average number of over 78 million uniquely mapped read pairs in 
Poly(A)+ samples and over 54 million in the poly(A)-. As expected, most introns’ splicing is 
fully completed in the cytosolic fraction. However, it is interesting to note that the Poly(A)- 
samples have lower SE in all fractions when compared to their Poly(A)+ counterparts 
(Wilcoxon's test, P ≤ 0.0001). The poly(A)- nuclear fraction has the lowest SE, while Cell 
Poly(A)+ shows the highest. The high SE in the former suggests that splicing is happening 
shortly after transcription is completed. Assessing the kinetics of pre-mRNA splicing in 
subcellular fractions with SPLICE-q provides valuable information concerning the co-
transcriptionality of this process and allows the interrogation of the fraction of introns which 
are post-transcriptionally spliced.  
2.  Analysis of prostate cancer data 
Lastly, we show how SPLICE-q can also be applied to quantify intron retention in total 
RNA-Seq data. For this purpose, we used data coming from a prostate cancer sample along 
with its matched normal tissue (patient 15 of ref. [86]). Since for each of the tissues two 




replicates were available, we computed splicing efficiencies for each replicate and then 
averaged the results for the tumor tissue and the normal tissue.  
Prostate cancer is one of the most common cancer types in men [114]. SPLICE-q 
detected relatively high splicing efficiencies—median SE of 0.96 in both the tumor and the 
normal sample—in the 66,389 introns shared across the sample pair after running the tool with 
default parameters. This is expected when the tool is applied to steady-state RNA-Seq data. 
Although this overview suggests that there is no alteration in average splicing efficiency levels 
between normal and tumor tissue, a closer look showed interesting changes for individual 
introns. One intriguing example is Prostate cancer associated 3 (PCA3), a long noncoding 
RNA highly expressed in prostate cancer and widely known as a prostate-specific biomarker 
of high specificity [115]. It has been found to be involved in the proliferation and survival of 
prostate cancer cells by multiple mechanisms, including the modulation of androgen receptor 
signaling, the inhibition of the tumor suppressor PRUNE2, and possibly by acting as a 
competing endogenous RNA (ceRNA) for high mobility group box 1 (HMGB1) protein via 
sponging of miR-218-5p [115]–[117]. Interestingly, PCA3’s second intron located at 
chr9:76,782,833-76,783,704 has an SE of 0.57 in normal tissue and a much higher SE of 0.90 
in the tumor (Figure 2a), suggesting that PCA3 might not only be overexpressed but also more 
efficiently spliced.  
Variation in splicing efficiency can be also observed among protein coding genes. The 
retinoic acid-related orphan receptor β (RORβ, encoded by the gene RORB) was recently 
reported to inhibit tumorigenesis in colorectal cancer in vivo. When RORβ was overexpressed, 
the tumorigenic capacity of the cells was significantly reduced, suggesting that this protein acts 
as a tumor suppressor in colorectal cancer [118]. In agreement with these previous findings, 
we found two of the RORB introns—located at chr9:74,630,368-74,634,630 and 




chr9:74,634,773-74,642,413—having reduced splicing efficiencies in the tumor sample (SEs 
of 0.99 and 0.98 
 
Figure 2: Processing dynamics profile of introns in prostate cancer and normal samples. IGV 
views of representative cases of introns from different genes comparing prostate cancer vs. normal 
samples. a) Intron located at chr9:76,782,833-76,783,704 from PCA3; b) Introns located at 
chr9:74,630,368-74,634,630 and chr9:74,634,773-74,642,413 from RORB; and c) Intron located at 
chrX:100,662,368-100,664,773 from SRPX2. Tumor and normal samples are represented in red and 
blue, respectively. 
 
in the normal control and 0.63 and 0.60 in the tumor, respectively) (Figure 2b).  Contrasting, 
Sushi repeat-containing protein X‐linked 2, or simply SRPX2, shows the opposite splicing 
efficiency profile with an intron at the coordinates chrX:100,662,368-100,664,773 being less 
efficiently spliced in the control sample (SE of 0.59) than in the tumor (SE of 0.90, Figure 2c). 
Previous studies showed SRPX2 playing an important role in cancer development and 
progression. In colorectal cancer, the overexpression of SRPX2 may promote the 
invasiveness of tumor cells [119], and in prostate cancer, a knockdown of SRPX2 affected the 
proliferation, migration and invasion of cancer cells by partially suppressing the 
PI3K/Akt/mTOR signaling pathway [120]. PI3K/Akt/mTOR regulates cell proliferation and 




survival in different cancer types and is usually activated in advanced prostate cancer [121], 
[122]. Furthermore, the suppression of this signaling pathway was reported to reduce cell 
motility and invasion in prostate cancer  [123]. These examples illustrate that gene regulation 
may go beyond the mere expression levels, with a gain or loss of splicing efficiency potentially 






































Chapter IV: Splicing Dynamics 
In the previous chapters, we showed that splicing efficiency can be determined with 
certain molecular biology approaches or different frameworks including challenging 
bioinformatics steps. We introduced SPLICE-q, a tool that makes it possible to quantify 
splicing efficiency in a fast and precise way. But what is the relationship between splicing 
efficiency and the biology of the cell? What biological aspects could be influencing splicing 
kinetics? To answer these and many other questions, SPLICE-q was applied to globally assess 
the kinetics of intron excision. This chapter aims to provide an in-depth study to address 
questions concerning the differences in the speed of splicing and the underlying biological 
features that might be associated with it using time-course nascent RNA-Seq data. Those 
features include gene and intron length, gene and intron nucleotide composition (GC content), 
gene biotype, gene function and intron ordinal position. We also searched for motifs at splice 
junctions to look for relevant regulatory elements influencing the splicing dynamics. Lastly, 
we analyzed the RNA secondary structure elements and its RBP binding preferences as well 












1.  Dataset and clustering step 
To monitor splicing kinetics in human cells, we used RNA-Seq data from Human 
Embryonic Kidney 293 cells (HEK293) after labeling with the uridine analog BrU (BrU-seq). 
Shortly, the cells were incubated with 2mM of 5-bromouridine (BrU) and either collected 
immediately (0 Minutes) or chased for 15, 30 and 60 minutes prior to RNA purification. The 
data was mapped to the human genome (hg38) (see Chapter II). On average, we obtained 103 
million read pairs per sample and approximately 85% of those were uniquely mapped (Table 
1). These samples were compared to an unlabeled control with an average of 30 million paired-
end reads per replicate. Visual inspection of the mapped reads showed reads covering exonic 
and intronic regions in the BrU-Seq while the unlabeled control covered mostly exons. 
Table 1: Number of input reads per sample. 









0 107.855.496 83.78% 102.270.732 84.60% 
15 113.149.174 86.74% 94.402.826 83.61% 
30 103.679.161 89.48% 101.572.030 85.20% 
60 93.184.721 83.59% 110.250.800 84.61% 
  *Sample B comprises 2 technical replicates. 
 
SPLICE-q was applied using default parameters to quantify the splicing efficiency of 
all samples. The table of results for each sample in each time point was merged in order to 
keep only satisfying the filtering criteria in both samples at the same time. This totals 23.475, 
23.767, 21.532, 37.067 and 60.762 introns in 0, 15, 30 and 60 minutes and control, 
respectively. On the side of exploring the features shared by these introns according to their 
splicing efficiency, only those shared between in all samples at the same time were taken. This 
consists of 14.003 introns distributed in 3848 genes which satisfied SPLICE-q’s default 




filtering criteria (Figure 1a). As expected, SPLICE-q detects a progressive increase of splicing 
efficiency throughout the time course (Figure 1b). Samples were compared to total RNA to 
assess the steady-state levels of splicing.  
 
 
Figure 1: Splicing kinetics using BrU labeled RNA-Seq. a) Venn diagram showing the introns shared 
between all samples of the BrU-Seq dataset. b) Splicing efficiency throughout the time course.   
 
Only the 6024 introns whose SE has an absolute difference ≤ 0.2 between the two 
replicates for all the time points of the time series were considered for downstream analyses 
(Figure 2a). Two rounds of clustering were performed on individual introns using the average 
(per replicate) SE scores in each time-point. First, K-means clustering was computed with 
a) 
b) 




k = 70 (nstart = 100). Then, the centroids of each cluster were hierarchically clustered (Figure 
2a). Introns with SE in a given time-point diverging in 0.2 or more from the centroid of their 
cluster and clusters showing SEx+1 - SEx ≤ -0.2, with x indicating a time-point, were excluded. 
To further investigate the kinetics of intron excision and the possibly associated underlying 
biological features, three introns groups with distinct splicing efficiency were drawn from the 
second round of clustering after final filtering: (i) Fast: introns with SE(0Min) ≥ 0.75, i.e., 
introns with high level of co-transcriptional splicing; (ii) Intermediate: introns with 0.3 < 
SE(0Min) < 0.75 and SE(60Min) ≥ 0.75 ; and (iii) Slow: introns with SE(0Min) ≤ 0.3 and none 
of the efficiencies in the other time-points exceeding 0.4  (Figure 2b). These groups were then 
used to address questions concerning their splicing dynamics, i.e., the underlying biological 
features that might be associated with the differences in the speed of splicing. 
    
                              
Figure 2: Workflow for intron clustering. a) Representation of how the groups were extracted, 
guided by the results of the hierarchical clustering displayed as a dendrogram; and b) Average curve 
representing the three groups according to their SE patterns through the time course: Fast, Intermediate 













































2.  Biological features 
2.1  Gene architecture 
2.1.1  Length and nucleotide composition 
Genes and genomes are highly heterogeneous concerning their length and nucleotide 
composition. Previous studies showed how specially GC content has great variation in different 
genomic regions and species [124]–[126]. In higher eukaryotes’ genomes, sequences of high 
GC content are very common [127]. However, how nucleotide composition influences different 
patterns of splicing speed has yet to be explored.  
In the light of our data, we see a modest but significant increase of GC content in introns 
and genes of the Slow splicing group when compared to Intermediate and Fast (Figure 3A-D, 
P < 0.01, Wilcoxon rank test). This information alone is not enough to draw conclusions on 
how GC content might contribute to splicing kinetics. Thus, knowing that GC-rich genes are 
usually associated with smaller introns [128], we investigated whether our data would follow 
this trend. In agreement with literature, introns belonging to the Slow splicing group are 
significantly shorter than introns in groups Fast and Intermediate (P ≤ 0.05, Wilcoxon rank 
test). Not surprisingly, gene length follows the same trend, since introns are much longer than 
exons in the human genome [111]. Although the same study showed a strong negative 
correlation between intron length and GC content [128], this phenomenon cannot be observed 
in our data.  
It is widely known that the range of functional elements in introns interact with features 
of the exons [129]–[131]. Therefore, we checked for GC content and the length of exons 
flanking introns in each group (Figure 4). In all groups, the flanking exons are significantly 
GC-richer than the introns (P ≤ 0.01, Wilcoxon rank test). Previous studies showed this trend 
and also suggested that this difference might be linked to more efficient transcription and 
splicing [130], [132].  Additionally, exons in the Slow splicing group show significantly higher 




exonic GC content when compared to the Fast group (P ≤ 0.01, Wilcoxon rank test). A possible 
explanation for what could be influencing the higher GC content in the Slow splicing group is 
the assortment of gene types present in this group.  
 
Figure 3: Gene and intron nucleotide composition and length. A) GC content of the introns; B) GC 
content of the complete genes;  C) Length of the introns; and D) Length of the genes – defined as the 
number of nucleotides before splicing in the primary transcript [133].  
 
Figure 4: Nucleotide composition of exons. GC content of introns and flanking exons in each group. 




We confirmed this by checking the protein coding genes (PCG), Pseudogenes and 
lncRNA content in each group and, surprisingly, the Slow group is the one containing more 
non-coding genes: 25% against ~1% only in the other two groups and when compared to all 
the genes from this study (Figure 5). Furthermore, in the Slow splicing group, the exons from 
the PCG have significantly lower GC content than the exons in the lncRNAs (P ≤ 0.01, 
Wilcoxon rank test). The differences in GC content between introns and exons were suggested 
to be one of the factors strongly influencing elements linked to transcription and splicing, such 
as histone marks and nucleosome occupancy [129]. Furthermore, an increased GC content, 
including in lncRNAs, might be linked to GC-rich RNA secondary structures. We will discuss 
secondary structures later in this chapter. Exon length does not differ between groups (data not 
shown). 
 
Figure 5: Gene type. Distribution of gene biotypes in each group. Total = All genes from the 6024 
introns analyzed in this thesis.   
 
2.1.2  Intron ordinal position 
We hypothesized that in each group the introns closer to the TSS would have different 





















partially supported by literature, e.g., Chen and colleagues, in a study limited to only two 
chromosomes,  observed that the first introns are usually longer than the downstream introns 
[134]. In agreement with literature, we see that the first introns in the Fast group are 
significantly longer than the other introns in the same group (P ≤ 0.001, Wilcoxon rank test). 
However, this trend cannot be observed in the other groups (Figure 6). Also, first introns in 
the Fast group are longer than when compared to the first introns in the Intermediate and Slow 
splicing groups (P ≤ 0.01, Wilcoxon rank test, data not shown). The longer first intron in the 
Fast splicing group suggests that this feature might spatially allow the presence of more 
regulatory sequences that could, for instance, influence co-transcriptional splicing.  
 
Figure 6: Intron length according to its ordinal position. Interm. = Intermediate. 
 
 It is known that the GC content of the first introns is usually higher than the 
downstream counterparts in mammals [126]. We confirm this with our data, but, surprisingly, 
the Slow splicing group does not follow this tendency. In other words, in the Fast and 
Intermediate groups, the first introns are significantly GC-richer (P ≤ 0.01, Wilcoxon rank test) 
while in the Slow group the difference is not statistically significant (Figure 7). Furthermore, 
the last introns in the Slow splicing group have higher GC content when compared to the last 
introns in the other two groups (data not shown). 





Figure 7: Intron GC content according to its ordinal position. Interm. = Intermediate. 
 
2.2  Splice junctions 
Exons and introns are known to have unusual characteristics, like particular nucleotide 
composition, near their boundaries [135]. Thus, we analyzed limited windows of 100 bp at the 
exon-intron boundaries. Since GC content also plays a role in splice-site identification, it is 
logical to think that splicing kinetics could be affected due to an unusual nucleotide 
composition near the splice junctions. In agreement with our previous findings regarding the 
GC content of the genes in each group, the GC content in these windows is significantly higher 
in the Slow group, although here this increase is more pronounced. We also checked if the GC 
content would differ in the splice junctions according to the intron ordinal position. 
Remarkably, the 5’ SJs of the first introns in the Fast group have a much higher GC content 
with ~60% against a median of 38% in the 3’SJ. This difference remains but it is less evident 
in the Intermediate group while it disappears in the Slow group where both SJs have a median 
GC content of 45%. It is interesting to note that this scenario of GC-richer SJs in the Fast group 
is only observed in the 5’ SJ of the first introns (Figure 8A). For the 3’ SJs of the first introns 




and both SJs of the last introns, the trend of GC content increasing as splicing efficiency 
decreases holds (Figure 8B-D).  
 
Figure 8: Intron GC content at the exon-intron boundaries according to intron position. The 
windows around the splice junctions are limited to 100 bp. A) 5’ SJ of the first introns; B) 5’ SJ of the 
last introns; C) 3’ SJ of the first introns and D) 3’ SJ of the last introns. 
 
We also explored the relationship between splicing kinetics and splice-site strength 
using the MaxEntScan algorithm (see Chapter II). Splice-sites are known to have well 
conserved consensus sequences [105]. We see that although there is no variation between the 
5’ splice-sites of all groups, there is a small but significant decrease from Fast to Slow group 
in the 3’ splice-sites (Figure 9). The Slow group is also the only one to show a difference in 
conservation between both splice-sites. These findings are an indication that the sequences in 
these exon-intron boundaries diverge more from the expected consensus. In other words, those 
are “weaker” splice-sites. Together with the difference in GC content, the splice-site strength 
may be contributing to slower RNA processing kinetics in distinct ways, such as sequence 




recognition by the spliceosome components and accessory proteins, RNA secondary structure 
and exon inclusion signaling.   
 
Figure 9: Splice-site strength. Splice-site strength using the Maximum Entropy method from 
MaxEntScan algorithm. 
 
2.2.1  Donor-acceptor consensus sequences 
As previously described in Chapter I, during splicing, introns are removed, and exons 
are precisely ligated. In the first splicing step, U1 snRNA interacts through base pairing with 
the 5' splice-site donor site consensus sequence GU and its surrounding nucleotides. The 
interaction with the AG dinucleotide (acceptor site) occurs mostly in the second step of the 
splicing reaction. The donor-acceptor GU-AG (GT-AG in the DNA) consensus sequences are 
present in more than 95% of the introns in mammalian genomes [7]. Variations in the donor-
acceptor sequences may influence splicing efficiency and kinetics. Accordingly, we checked 
these sequences in each of the groups. We observed that the groups Fast and Intermediate 
present GT-AG consensus in all the sequences (Figure 10A) while introns in the Slow group 
show a higher frequency (6.06%) of the major splice site variant GC-AG (Figure 10B). It is 
important to remember that redundant introns were not considered for this analysis. It has been 




reported that this non-canonical splice-site accounts for only 0.56% of mammalian genomes 
[7]. As well as GT-AG, GC-AG splice sites are also recognized by the U2-type spliceosome 
[6]. However, the C mismatches with U1 when this snRNA interacts with the dinucleotide. 
Thanaraj and Clark [136] showed that 62% of the introns containing GC-AG consensus 
sequences are alternative introns and later it was also shown that alternative splicing events are 
associated with lower splicing kinetics [84]. Based on this previous finding, our results support 
the hypothesis that a non-canonical donor site together with a weaker 3' splice site are important 
factors contributing to the lower splicing efficiency of these introns.  
 
Figure 10: Consensus sequences at donor and acceptor splice-sites. The size of the letter indicates 
the relative frequency at that nucleotide position. A) Fast and Intermediate groups and B) Slow group. 
 
3.  Motif enrichment analysis 
A sequence motif is a short recurring nucleotide or amino acid pattern presumably 
holding a biological meaning. These sequences can be an indication of specific binding sites 
for numerous proteins such as transcriptions factors. Some motifs are also involved in mRNA 
processing, specially splicing [137]. 
An important goal of molecular biology and bioinformatics is to explain in detail the 
mechanisms controlling gene transcription. One common approach is to assess whether the 
regulatory sequences of a group of genes are enriched, i.e., have greater affinity than expected 
for a regulatory element for which a given motif is known [138]. 
 
 




3.1  Transcription start sites 
 In order to evaluate how transcription factors and other DNA binding proteins could 
influence the splicing dynamics, we first performed a motif enrichment analysis in the promoter 
regions of the sets of genes which contain the introns of the individual splicing groups. Motifs 
of length 8 to 20 nucleotides were searched from -400 to +100 relative to each gene TSS, as 
described in Chapter II.  
The results were inspected in terms of enrichment and significance, with the four more 
significant motifs displayed in Figure 11A-D. In the Fast and Intermediate splicing groups, 
Transcriptional repressor protein YY1’s motif is present in 12.67% of the sequences (P < 
0.000001), while not present in the Slow group. This is a ubiquitous zinc finger transcription 
factor that acts through directly or indirectly activating or repressing numerous genes by 
binding to sites overlapping the transcription start site. YY1 also promotes conformational 
DNA changes, such as the formation of loops that allow interactions between enhancer and 
promoter. Its dysregulation disrupts enhancer-promoter loops and gene expression [139].  
43.11% of which sequences in the Fast splicing group present the transcription activator 
ETS domain-containing protein Elk-1 (P < 0.001). Elk-1 represents an essential link between 
ras-raf-MAPK signal transduction pathways and the initiation of gene transcription [140]. 
Other two important transcription activators whose motifs presented enriched in this group are 
Transcription factor E2F4 (40.89%, P < 0.001) and Myc proto-oncogene protein (c-Myc; 
23.78%, P < 0.01). The former is a member of the E2F family that plays a role in cell cycle 
regulation and DNA replication by binding to the promoter region of several genes [141]. 
Although most E2F4 binding sites are located near transcription start sites (~56%) and 
contribute to direct activation of transcription, other sites are often localized more than 20 kb 
away from annotated TSSs, suggesting that E2F4 can also serve as a long-range transcriptional 
regulator [142] and play a role in the splicing dynamics. The latter activator of interest, c-Myc, 




has the recruitment of histone acetyltransferases as one of its functions [143] - histone 
acetylation is associated with transcriptional activation - and interacts with other proteins to 
activate gene expression via RNA polymerase II pause release [144]. Elk-1, E2F4 and c-Myc 
do not appear in the Slow group and only E2F4 is present in the Intermediate group, as 





Figure 11: Enriched binding motifs in TSS regions of fast splicing genes. A) Transcriptional 
repressor protein YY1; B) ETS domain-containing protein Elk-1; C) Transcription factor E2F4 and D) 
Myc proto-oncogene protein binding motifs. 
 
The group comprising the introns with intermediate splicing speed present motif 
enrichment of a mixture of transcription activators and repressors (Figure 12A-D), specially 
the members of the E2F family. E2F7 and E2F6, both transcription repressors [145], [146] 
appear in 20.35% (P < 0.000001) and 42.81% (P < 0.0001) sequences, respectively. E2F3 and 
E2F4 [142], [147] are some of the transcription activators whose binding motifs are enriched 
in this group appearing in 47.02% (P < 0.001) and 44.21% (P < 0.001) of the total sequences, 
respectively. None of these transcription factors are present in sequences from group Slow and, 
as described before, only E2F4 motif appears in group Fast, in 40.89% of the sequences. 
Lastly, the group formed by introns with slow splicing has enrichment for Transcription 
regulator Kaiso (ZBTB33) binding motif (Figure 12E). With its motif enriched in 12.5% 
(p<.01) of the sequences, this protein belongs to a group of zinc finger proteins that represses 
transcription by binding to methylated regions [148]. ZBTB33 also represses transcription by 
recruiting other complexes associated with the formation of repressive chromatin structures in 




promoter regions [149]. None of the other groups have enrichment for the ZBTB33 binding 
motif. 
A)   B) 
           
C) D) 





Figure 12: Enriched binding motifs in TSS regions of intermediate and slow splicing genes. A) 
Transcription factor E2F7; B) Transcription factor E2F6; C) Transcription factor E2F3; D) 
Transcription factor E2F4 and E) Transcription regulator Kaiso. 
 
3.2  RBPs in the intronic regions 
3.2.1  Fast splicing 
RNA-binding proteins (RBPs) play an important role in numerous cellular processes, 
including splicing and pre-mRNA stability. RBPs specifically bind to motifs and identifying 
these sequences is crucial to the understanding of RNA processing dynamics and its regulatory 
mechanisms. In order to evaluate how RBPs could influence the splicing dynamics, we 
performed motif enrichment analysis in the intronic sequences in the Fast and Slow splicing 
groups.  
Interestingly, the Fast splicing group shows enrichment for three poly(A)-binding 
proteins (PABP1, PABP4 and PABP5) – PABs (Figure 13A). Although the PABs are mainly 
known for the role they play in the translation initiation pathway [150], [151],  it was also 
shown by Muniz, Davidson, and West that PABP1’s function in mRNA polyadenylation 
supports pre-mRNA splicing in human cells [152]. They also discussed PABP1 binding to 
internal A-tracts and showed that the absence of polyadenylation leads to low splicing 




efficiency and that PABP1 depletion caused significant reductions in spliced RNA and splicing 
efficiency. Their study also suggests that PABP1 might promote the binding of splicing factors 
to introns.  
A)  
   
 
B)  C)  
     
Figure 13: Enriched binding motifs in intronic regions of fast splicing genes. A) Poly(A)-binding 
proteins (PABP1, PABP4 and PABP5, respectively); B) ELAV-like protein 1; and C) Squamous cell 
carcinoma antigen recognized by T-cells 3. 
 
Furthermore, ELAV-like protein 1 (ELAVL1 or HuR) also shows binding preference in 
this group (Figure 13B). HuR is a ubiquitous protein member of the ELAV/Hu family that 
binds to uridine tracts occurring primarily within introns and 3′ untranslated areas, correlating 
with its role as a regulator for splicing and mRNA stability. Transcripts containing both intronic 
and 3’ UTR HuR binding motifs show a more stable pre-mRNA and this might be associated 
with a higher splicing efficiency [153]. Additionally, to understand the role of this RBP in pre-
mRNA splicing, Diaz-Muñoz and colleagues  knocked out HuR in B cells and were able to see 
an increase of intron retention. They suggest that HuR’s absence is linked to aberrant intron 
inclusion and, like other splicing regulators, HuR promotes efficient splicing and provides a 
quality-control mechanism for the transcriptome. 
Squamous cell carcinoma antigen recognized by T-cells 3 (SART3) is another 
interesting enriched element (Figure 13C). SART3 is expressed in most proliferating cells and 
it was previously suggested SART3 plays a role in pre-mRNA splicing regulation through 
interactions with RNPSI – a known splicing activator protein [155]. Shortly after, it was 




reported that SART3 is also a U6 snRNP-binding protein that functions as a splicing machinery 
recycling factor. It promotes the reannealing of the snRNPs U6 and U4 after being ejected by 
the spliceosome machinery during its maturation [156]. These findings are a strong 
contribution to how SART3 might play a role in promoting faster and more efficient splicing.  
3.2.2  Slow splicing 
  RNA-binding motif protein 5 (RBM5) is the first enriched site in the group of slowly 
spliced introns (Figure 14A). RBM5 mediates splice sites pairing after the recruitment of U1 
and U2 snRNPs to both splice sites of the intron. RBM5’s effect on AS resembles the 
Polypyrimidine tract-binding protein (PTB or hnRNP I) function. The latter is a repressive AS 
regulator. A study also revealed that high levels of RBM5 resulted in significant events of 
retention in Tumor necrosis factor receptor superfamily member 6 (Fas) [157]. On the other 
hand, the depletion of RBM5 led to enhanced splicing of individual introns. Furthermore, 
RBM5 also inhibited the complete assembly of the spliceosomes [157]. Altogether, these 
findings confirm that RBM5 function is directly associated with the splicing process and is 
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Figure 14: Enriched binding motifs in intronic regions of slow splicing genes. A) RNA-binding 
motif protein 5; B) Serine/arginine-rich splicing factor 1 and 9, respectively; and C) Heterogeneous 
nuclear ribonucleoproteins A2/B1. 
 
Interestingly, SRSF1, SRSF9 and hnRNPA2/B1 are enriched in this group (Figure 
14B-C). Serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins 




(hnRNP) proteins are two important classes of splicing factors (SF). In other words, they have 
a direct influence on splicing through binding specific sites in targeted RNAs and by interacting 
with the spliceosome [158]. It is also important to highlight that although SR proteins bind 
preferentially to exonic sequences, they also have numerous binding sites within introns [159], 
[160]. Surprisingly, SRSF1 – a known splicing activator [160] – is enriched in this group. 
However, Buratti and colleagues showed this SF can also bind to intronic splicing silencers 
[161]. On the other hand, SRSF9 and hnRNPA2/B1 act mainly as splicing repressors [160]. 
These findings are consistent with the slower splicing speed displayed by this group of introns.    
3.3  RNA structural elements 
One of the many properties of RNA molecules is the ability to form secondary 
structures in vitro and in vivo [162]. These structures vary and function as regulatory 
mechanisms of the cell, such as splicing [163]. It is known that splicing regulators depend not 
only on motif sequences but also on RNA secondary structures for binding site recognition 
[106]. Thus, we used the RBP motif server [106], [164] to investigate the sequences and 
structural binding preferences of RBPs with motif binding sequence length ranging from 4-12 
nucleotides in windows of 100nt around the splice junctions (-49nt/SJ/+49nt; see Chapter II).  
The different structural contexts vary greatly when comparing Fast and Slow groups. 
In group Fast, the 5’ splice site has paired regions as the most preferred secondary structure 
and internal loops as the least. At the same time, the 3’ side also shows paired structures as 
preferred folding context while the least favorite are the multiloops. The secondary structure 
profile of the group Slow consists of internal loops as the most favored structure and, opposite 
to group Fast, paired as the least in the 5’ side. As for the 3’ side, multiloops are seen as the 
most preferred structures while paired and hairpins are the least. This is interesting and coherent 
by reason of paired being the most common RNA secondary structure [14]. It suggests that the 
splicing machinery evolved together with these structures. However, it has also been reported 




that paired structures near or at the donor-acceptor sites function as a barrier for splicing 
regulatory elements. In order to avoid disrupting splicing signals, optimal paired structures 
should be located at least 50 nt away from these sites [165]. Thus, to better investigate the 
influence of paired regions, we performed a finer search using the splice site windows modeled 
as described in [166]. Here, the structural contexts change drastically as it is shown in Figure 
15. 
  In the 5’ splice site of the group Fast, hairpin loops are the most preferred context in 
the secondary structure profile. Furthermore, paired and multiloop regions are the least 
preferred. The RBPs with similar binding preferences to the predicted sequence motifs are 
SRSF1 (P < 0.005), SRSF2 (P < 0.006) and SRSF9 (P < 0.001). While SRSF1 and SRSF2 are 
activators necessary for the splicing reaction to happen [160], [167], SFSR9 acts mainly as a 
splicing repressor [160]. For the 3’ splice site still in the group Fast, multiloops followed 
closely by hairpin loops are the most preferred structural context while internal loops are the 
least. No significant RBPs with similar structural binding preferences were found. Although it 
was reported that hairpin loops can act as splicing inhibitors [168], it is important to note that 
splicing factors are dependent on secondary structure and the majority of SR proteins are 
potentially influenced by RNA conformation [169]. Also, hairpin loops at the 3’ splice site are 
reported to play a role in splicing regulation through forcing conformational changes in the BP 
that would enhance the recognition by the spliceosome [170] and bring together elements that 
are far away [162].  
On the other hand, the group containing slowly spliced introns shows external loops 
and paired structures as the most preferred in the 5’ splice site and internal loops in the 3’ splice 
sites. The least preferred secondary structures are hairpin loops and multiloops for 5’ and 3’ 
splice sites, respectively.  





Figure 15: RNA secondary structure binding preferences. The secondary structure contexts are 
scaled with the most preferred equals to 1. ss = splice site.  
 
Interestingly, in the 5’ splice site, the RPBs with similar structural binding preferences 
are Retinol-binding protein 1 (RBP1; P < 0.002), a known E2F-dependent transcription 
repressor [171]. RPB1 can also repress splicing through intronic silencers [172]. Pumilio 
homolog 2 (PUM2; P < 0.002) has similar binding preferences to the motifs found in the 3’ 
splice site. Reports showed that this protein acts as a posttranscriptional repressor [173].  
These findings suggest that secondary structure is not only related to splicing regulation 
but may also play a significant role in splicing kinetics. Different structural contexts, such as 
the presence or absence of hairpin loops, seem to correlate with splicing efficiency and kinetics 




when it potentially functions to bring closer distant regulatory sequences or influence the 
















































1.  Discussion 
1.1 SPLICE-q facilitates the quantification of splicing efficiency 
Splicing is an essential and highly regulated step of eukaryotic gene expression. The 
abnormal removal of introns can lead to many human diseases. We have introduced SPLICE-
q, a python tool for genome-wide determination of splicing efficiency of individual introns 
from RNA-Seq data. To recapitulate, SPLICE-q uses aligned reads from RNA-Seq to quantify 
splicing efficiency in two different methods: Splicing efficiency (SE) and inverse intron 
expression ratio (IER). The former takes both split and unsplit reads spanning the 5’ and 3’ 
splice junctions of a given intron while the latter consists of an alternative measure which 
compares the introns’ expression levels with those of their flanking exons. SPLICE-q also 
allows the user to select different levels of restrictiveness concerning the introns’ overlap with 
other genomic elements, such as introns overlapping exons from other genes. This is an 
important feature since it overcomes issues caused by ambiguous read assignment. 
SPLICE-q provides two quantification methods, both relying on counting sequencing 
reads. The main quantification method, SE, offers some advantages: besides providing an 
estimation of splicing efficiency without biases, it does not require normalization corrections. 
However, SE is sensitive to read coverage in the splice junctions, which depends heavily on 
expression and sequencing depth. For example, in time-series studies involving very early time 
points, splice junctions might show a very low number of reads. SPLICE-q applies a default of 
a minimum of ten reads spamming each splice junction of an intron to avoid uncertainties in 
the quantification. This cutoff can be modified. 
The other quantification method, IER, uses the median per-base read coverage of a full 
intron and its flanking exons. Although IER does not suffer from the low-covered splice 
junctions, it comes with a need for normalization. Furthermore, while working with protein 
coding genes, the gene architecture should be carefully considered.  For example, highly 




covered introns will lead to a low splicing efficiency and this value can be artificial if this intron 
harbors many snoRNAs [174]. Some may also argue that the splicing efficiency may be 
underestimated due to the presence of the intron lariat.  Making a distinction between reads 
deriving from the pre-mRNA introns and the lariat is not always possible [175]. However, 
based on previous studies attempting to identify intron lariats [175], we do not consider this 
issue when it comes to SPLICE-q’s IER quantifications. Lastly, it is very important to consider 
whether pre-mRNA degradation would affect SPLICE-q’s estimate but, when it comes to 
degradation, introns are removed together with exons [176], [177] therefore not affecting our 
quantifications.  
When it comes to deciding between which quantification method is best, the sequencing 
depth, number of replicates and the biological question should be considered. However, we 
strongly recommend the use of both approaches combined for all the reasons mentioned above. 
1.2 SPLICE-q can be applied to different types of RNA-Seq 
SPLICE-q can be applied to strand-specific RNA-Seq data from any species. One 
interesting strategy to quantify splicing efficiency though is with the use of nascent RNA-Seq 
where the millions of reads obtained reflect the spliced and yet unspliced primary transcripts. 
It is important to mention that nascent RNA should be compared to total RNA (steady-state) 
[174]. We have chosen different datasets to show the tool’s applicability, including time-series 
nascent RNA-Seq of human and yeast and human subcellular fractions sequencing. SPLICE-q 
was able to detect a progressive increase of SE throughout the time course, provide information 
concerning the co- and post-transcriptionality of splicing in different cell compartments, 
respectively.  
SPLICE-q was also applied to total RNA-Seq data. Although the read coverage profile 
over gene bodies in this type of sequencing shows reads covering mostly exons, SPLICE-q can 
still provide considerable information, specially, but not necessarily, if conditions are being 




compared (e.g., normal vs. cancer cells). As explained in Chapter I, intron retention is a type 
of alternative splicing and when this event occurs, it is possible to detect reads mapping to the 
introns. When working with patient-specific data, SPLICE-q can provide information that 
allows the comparison of differences in splicing efficiencies between patients or between the 
pairs of samples of an individual patient. In conclusion, SPLICE-q can be used to quantify 
intron retention or aberrant splicing due to, for example, mutations in the splice junctions and 
may therefore provide new insights into the molecular basis of genetic diseases and cancer 
biology.  
1.3 SE values revealed different patterns of splicing over a time course 
We applied SPLICE-q to a time-series nascent RNA sequencing to globally assess the 
kinetics of intron excision. Briefly, the dataset consists of BrU-labeled cells with 15 minutes 
pulse labeling of nascent RNA and subsequent sequencing of labeled RNA after 0, 15, 30, and 
60 minutes (pulse-chase) [78]. The nascent RNA samples were compared to an unlabeled 
steady-state control. We were again able to clearly see the progressive increase of SE 
throughout the time course. Previous studies showed that splicing is predominantly co-
transcriptional in humans and for the most part happens immediately after the transcription of 
an intron is completed, when the RNA polymerase has proceeded only a few bases into the 
downstream exon [45], [48], [51]–[53]. Consistent with this, we saw that at 0 and 15 minutes, 
SE scores are already high with a median of 0.71 and 0.75, respectively. However, the results 
also illustrate that even 60 minutes after the pulse-labeling of RNA currently being transcribed, 
there is a significantly larger fraction of introns which have not yet been excised from the 
transcripts than in the steady-state control.  
We performed clustering using the individual intron average (per replicate) SE scores 
in each time-point. From the clustering, we were able to see that different groups of introns 
assume different splicing patterns over the time course. While some present high levels of from 




0 and 15 minutes, others have their SE increasing gradually or not increasing at all, being then 
indicative of very slow splicing or introns retention. A variety of biological features might be 
linked to these different splicing patterns and we will be discussing them in the next sections.  
1.4  Splicing dynamics depend on biological features 
We provided an in-depth study to address questions concerning the differences in the 
speed of splicing and the underlying biological features that might be associated with it using 
time-course nascent RNA-Seq data. Those features included gene and intron length, gene and 
intron nucleotide composition (GC content), gene biotype, gene function and intron ordinal 
position. We also searched for motifs at introns and splice junctions to look for relevant 
regulatory elements influencing the splicing dynamics. We also analyzed the RNA secondary 
structure elements and their RBP binding preferences as well as features associated with exons 
and UTRs. The most prominent results are discussed in the following subsections. 
1.4.1  Gene architecture and splicing speed 
Genes and genomes are highly heterogeneous concerning their length and nucleotide 
composition. We investigated how these features possibly influenced different patterns of 
splicing speed. Our data showed a modest but significant increase of GC content in introns and 
genes of the Slow splicing group. We also observe variation for exons. While we find exons 
being GC-richer than introns, which agrees with literature [130], [132], we also see that exons 
part of the Slow group have higher GC content. This variation in nucleotide composition may 
imply other factors known to regulate transcription and that could also regulate splicing such 
as DNA methylation [178]. High GC content may be linked to the presence of more CpG 
islands which are known to be involved in transcriptional regulation, specially in introns closer 
to the 5'-end of the gene. When a CpG is methylated, the chromatin structure is altered in a 
way that inhibits TFs binding [178]. 




We see that introns belonging to the Slow splicing group are significantly shorter than 
introns in groups Fast and Intermediate. These results are aligned with literature showing that 
GC-rich genes are usually associated with smaller introns [128]. Furthermore, previous data 
showed the lengthening suffered by introns during evolution [179]–[181]. Together with an 
analysis of our results, we suggest that this lengthening probably evolved in parallel with other 
factors, such as regulatory sequences and secondary structures, which provide a more efficient 
splicing. 
1.4.2  Splicing differences between coding and non-coding genes 
Our study also provided insights into differences in splicing kinetics of introns part of 
different gene types. What led us to this into questioning these differences, was whether the 
possible explanation for what could be influencing the higher GC content in the Slow splicing 
group was the assortment of gene types present in this group. In other words, we hypothesized 
that the higher GC content in the introns from the Slow group could be linked to the presence 
of more non-coding genes. Tilgner and colleagues [52] previously indicated that lncRNAs are 
less efficiently spliced. Confirming, we showed the Slow group containing more non-coding 
genes: 25% against ~1% only in the other two groups and when compared to all the genes from 
this study. Further supporting our findings, an extensive study on RNA metabolism profiles in 
coding and non-coding genes from Mukherjee and colleagues [84] found that lncRNAs 
exhibited lower synthesis, processing and stability than protein coding genes. However, the 
differences in gene classification in the different annotations and the lack of studies linking 
lncRNA features to splicing make it difficult to draw further conclusions. Yet, our results 
provide an important step toward the understanding of lncRNAs processing. 
 
 




1.4.3 Importance of regulatory RNA motifs and secondary structure  
Regarding the canonical splicing signals, introns in the Slow group show weaker splice 
sites and a higher frequency of the major splice site variant GC-AG. Variations in the donor-
acceptor sequences may influence splicing efficiency and kinetics. It was previously revealed 
that over 60% of the introns containing GC-AG consensus sequences are alternative introns 
and later it was also shown that alternative splicing events are associated with lower splicing 
kinetics [84]. As well as GT-AG, GC-AG splice sites are also recognized by the U2-type 
spliceosome [6] (see Chapter I). However, the C mismatches with U1 when this snRNA 
interacts with the dinucleotide. Based on this knowledge and the previous findings, our results 
support the hypothesis that a non-canonical donor site together with a weaker 3' splice site are 
important factors contributing to the lower splicing efficiency of these introns. We also suggest 
that as this non-consensus donor site still interacts with the same component of the spliceosome 
(U1 snRNA), the variation of one nucleotide interferes considerably in the splicing efficiency.  
It is widely known that RNA fold into secondary structures and these function as a 
regulatory mechanism for intron removal [163]. In other words, splicing regulators can be 
affected by or affect the RNA secondary structures when it comes to recognizing binding sites 
[106]. Using the RBP motif server [106], [164] (see Chapter II), we investigated the sequences 
and structural binding preferences of RBPs in windows around the splice junctions. The 
different structural contexts vary greatly when comparing Fast and Slow groups. For example, 
the presence or absence of hairpin loops, seeming to correlate with splicing efficiency when it 
potentially functions to bring closer distant regulatory sequences or influence the ligation of 
splicing enhancers and silencers.  
Furthermore, the GC content regional variation also contributes to the construction of 
a weaker or stronger secondary structure [165]. We see that the introns in the Slow group have 
significantly higher GC content in the splice junctions than the introns from other groups. To 




additionally support these results, previous analysis showed that GC-rich splice sites are 
associated with alternative splicing [182] and that this event is linked to slower splicing [84]. 
It is also interesting to note that lncRNA fold less stably than mRNAs [183] and this gene type 
is strongly present among the Slow group genes. Lastly, statistical analysis of coding sequences 
from mRNAs uncovered that the mRNA folding observed is more stable than what is expected 
by chance. This suggests that codon bias is probably favoring the presence of mRNA structures 
[184] and should be further investigated.  
There are many other factors that may or are in some aspect correlated and interfere 
with splicing efficiency: the presence of enhancer and silencer elements, the rate of RNA 
processivity, RNAPII pausing, characteristics of the branchpoint and polypyrimidine tract, 
other steps of gene expression, even modifications by external stimuli and so forth. The reason 
why so many factors are needed reflects that splicing is an extremely complex mechanism that 
should be further explored with integrative approaches.  
2.  Conclusion 
We introduced SPLICE-q, an efficient and user-friendly tool for splicing efficiency 
quantification. SPLICE-q enables the quantification of splicing through two different methods 
(SE and IER) and is sensitive to the overlap of genomic elements. We demonstrated SPLICE-
q’s usefulness by showing three use cases, including two different species and experimental 
methodologies. Our analyses illustrate that SPLICE-q is suitable to detect a progressive 
increase of splicing efficiency throughout a time course of strand-specific nascent RNA-Seq 
data. Likewise, SPLICE-q can be applied to strand-specific steady-state RNA-Seq data and 
might be useful when it comes to understanding cancer progression beyond mere gene 
expression levels. Both strategies have advantages or limitations depending on the data type 
and biological question to be answered and, choosing an intron-centric approach makes it 
possible to investigate splicing kinetics and co-transcriptional splicing between genes and 




between introns within the same gene. Lastly, we provided a comprehensive analysis showing 
the relationship between splicing efficiency and how various underlying biological features 

























AC Agglomerative coefficient 
AHC Agglomerative Hierarchical Clustering 
AS Alternative Splicing 
BP Branch Point 
C Cytosine  
DNA Deoxyribonucleic Acid 
G Guanine  
lncRNA Long Non-Coding RNA 
MEA Motif Enrichment Analysis 
mRNA Messenger RNA 
PCG Protein Coding Gene 
pre-mRNA precursor messenger RNA 
RBP RNA Binding Protein 
RNA Ribonucleic Acid 
RNAP RNA Polymerase 
RNA-Seq RNA Sequencing 
RNP Ribonucleoprotein 
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Eukaryotische Gene bestehen im Wesentlichen aus einer Reihe von Exons, die durch nicht-kodierende 
Sequenzen (so genannte Introns) getrennt sind. In einem posttranskriptionellen Prozess, der als Splicing 
bzw. Spleißen bezeichnet wird, werden diese Sequenzen üblicherweise aus den primären Transkripten 
entfernt, sodass reife RNA Moleküle entstehen. Effizientes Splicing der primären Transkripte ist ein 
derart essenzieller Schritt in der Expression von Genen, dass dessen Deregulation Ursache zahlreicher 
Erkrankungen des menschlichen Körpers ist. Deswegen ist es wichtig die Effizienz des Spleißens robust 
quantifizieren zu können, um die Dynamik dieses Prozesses und die Auswirkungen der aberranten 
Prozessierung von Transkripten besser zu verstehen. In diesem Manuskript präsentiere ich SPLICE-q, 
ein effizientes und benutzerfreundliches Pythonprogramm zur genomweiten Quantifizierung von 
Spleißeffizienzen (SPLICing Efficiency quantification). Es unterstützt u.a. Studien, die den Effekt von 
Spleißeffizienz auf die generelle Dynamik der Transkriptprozessierung untersuchen. SPLICE-q benutzt 
alignierte Reads aus RNA-Seq Experimenten, um die Spleißeffizienz für jedes einzelne Intron zu 
quantifizieren und erlaubt es dem Benutzer Introns in mehreren unterschiedlich restriktiven Stufen nach 
deren Überlapp mit anderen genomischen Elementen (bspw. Exons aus anderen Genen) zu filtern. Die 
Verwendung und Robustheit von SPLICE-q wird anhand von drei verschiedenen 
Anwendungsbeispielen, inkl. zweier unterschiedlicher Spezies und Methodologien, gezeigt. Diese 
Analysen demonstrieren, dass SPLICE-q in der Lage ist sowohl, anhand von Daten eines nascent RNA 
Experiments, einen progressiven Anstieg der Spleißeffizienz über die Zeit festzustellen, als auch zum 
Verständnis der Entwicklung von Krebszellen, über die bloße Genexpression hinaus, beizutragen. 
Darüber hinaus, untersucht diese Arbeit eine Zeitreihe aus nascent BrU-Seq-Daten im Detail, um 
Fragestellungen bzgl. Differenzen in der Spleißgeschwindigkeit in Verbindung mit gewissen 
biologischen Merkmalen zu klären. Der Quellcode von SPLICE-q und dessen Dokumentation sind 
öffentlich zugänglich unter: https://github.com/vrmelo/SPLICE-q. 
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